SlideShare ist ein Scribd-Unternehmen logo
1 von 7
Downloaden Sie, um offline zu lesen
Despite notable achievements,
there remains much to do
FUNDING FOR RESEARCH
COULD SAVE MANY LIVES
THE UK IS PLAYING
STROKE CATCH-UP
GAMING TECH
AIDS RECOVERY
BREAKTHROUGHS
IN STROKE BATTLE
Innovative procedures and
drugs are giving new hopeThere is a desperate shortage of funding for stroke research
Gaming technology can
improve at-home therapy
03 06 09 11
06 / 04 / 2016INDEPENDENT PUBLICATION BY #0370raconteur.net
UNDERSTANDING
STROKE
I
t strikes every three-and-a-
half minutes with devastating
results. Victims can be left se-
verely disabled with lifelong
care needs while one in eight strokes
results in death within 30 days.
Shifting age demographics and
lifestyles mean we are living longer
with more chronic illness, and al-
though stroke is a spectre of old age,
its potential to take and devastate
lives still ranks lowly in terms of pub-
lic perception and research funding.
The public is thought to fear can-
cer, heart disease and dementia
way above stroke. It is a discon-
certing view that can dilute fund-
raising and delay vital research
into an event that happens 152,000
times a year in the UK, according
to the Stroke Association’s State of
the Nation: stroke statistics report.
“Stroke is one of the biggest
health issues people face today
and it will take a life every 13 min-
utes,” says Jim Swindells, direc-
tor of fundraising at the Stroke
Association charity. “It is also the
leading cause of complex adult dis-
ability in the UK, and that can be
devastating for the survivor and
their loved ones.”
Stroke costs the nation an estimat-
ed £9 billion a year in health and so-
cial costs, but its funding is dwarfed
by other conditions. A massive £544
million (64 per cent) of the £856 mil-
lion spent on research in 2012 went to
cancer, while coronary heart disease
benefitted to the tune of £166 million,
but stroke trailed with £56 million.
Stroke incidence rates fell 19 per
cent from 1990 to 2010 through
improved services, according to a
report in The Lancet. But an ageing
population, combined with long-
term illness such as hypertension,
diabetes and atrial fibrillation
(AF), are a tinderbox for attacks
and the stroke burden, from illness
to premature death, is predicted to
double by 2030.
“It is very frustrating because
stroke is going under the radar
and, although it can be devastat-
ing, people are nowhere near as
afraid of it as they are of cancer,
heart disease and
dementia,” says
Mr Swindells.
“Weareconvinced
wecanmakesweep-
ing advances if we
get more funding.
There are exciting
areas of research
into preventing and
helping people re-
cover from stroke,
along with great
progress in the UK
on robot-assisted
rehabilitation and
theuseofstemcells.
“The cost of dealing with stroke
is enormous, so if we can prevent
it and help people recover quickly,
there will be a real economic bonus
for the country as well as the bene-
fit for patients.
“Until comparatively recently it
was thought that recovery from
stroke would be luck of the draw,
but we know the brain has plasticity
and can recover. Size matters with
research – and we need more funds.”
The Stroke Association has been
championing research for 25 years
as well as providing services for
survivors, while the British Heart
Foundation currently supports 29
research projects, with £13.9 mil-
lion invested directly into stroke,
and further funds a wide variety of
studies into atherosclerosis, a ma-
jor cause of stroke.
British universities and compa-
nies are also pushing the bound-
aries of innovation, and the
Bridgend-based firm ReNeuron is
showcasing promise with its novel
CTX stem cell therapy to regener-
ate motor function in stroke vic-
tims which is now in phase II clini-
cal trials.
But there is still
concern about
the UK uptake of
NOACs, a class of
drugs also referred
to as novel antico-
agulants, which
are prescribed to
reduce the risk of
stroke. Despite the
National Institute
for Health and
Care Excellence
(NICE) approving
their use as part of
a cardiovascular
strategy in 2014, figures showed
that less than 50 per cent of pa-
tients admitted to hospital with
stroke caused by AF had been tak-
ing medication.
The Association of the British Phar-
maceutical Industry’s Stroke Preven-
tion in Atrial Fibrillation Initiative
(SAFI) is concerned about the alarm-
ing range of NOAC prescription –
from 4 to 70 per cent – across clinical
commissioning groups (CCGs).
“This means patients are sub-
ject to a postcode lottery,” says Jo
Taylor, vice chairwoman of SAFI.
“Some 7,000 strokes and 2,000
premature deaths could be avoided
each year with effective manage-
ment of AF.
“Consistent adoption of NICE
guidance and widespread dissem-
ination of best practice in service
redesign in all CCGs is essential
to save lives and prevent what are
potentially avoidable AF-related
strokes, benefitting patients, the
NHS and the economy.”
Treatment of strokes falls into
two broad categories: acute care
where early treatment is vital;
and rehabilitation which can take
months or years.
The nation’s stroke services have
been revitalised over the last decade,
but rehabilitation is still the subject
of much concern with variable levels
of services and potential for dislo-
cation between the authorities that
share responsibility for post-hospi-
tal care in the community.
Patients are entitled to 45 min-
utes’ daily rehabilitation in hospi-
tal, be that occupational, speech or
physiotherapy, but experts fear the
gains are not always maximised
when the patient returns home.
In addition, the British Associa-
tion of Stroke Physicians warns of
gaps in the healthcare workforce
with 25 per cent of stroke plac-
es unfilled at training and con-
sultant level, along with nursing
shortages in some hyper-acute
stroke units.
Stroke services and public aware-
ness have improved significantly,
but the challenge to secure effec-
tive and accessible treatment for
all patients remains.
DISTRIBUTED IN
DANNY BUCKLAND
Award-winning health
journalist, he writes for
national newspapers
and magazines, and blogs
on health innovation
and technology.
KEVIN GROGAN
Specialist journalist
coveringthepharmaceutical
and healthcare sectors, he
writes for a wide variety of
publications on both sides
of the Atlantic.
JUDY HOBSON
Renowned health writer,
she has received awards
from the Medical Journalists’
Association, Research into
Ageing, and Excellence in
Cancer Reporting.
LORENA TONARELLI
Healthcare journalist,
she writes for The
Independent, The
Guardian and The
Economist, as well as
magazines and websites.
RACONTEUR
PUBLISHING MANAGER
Senem Boyaci
DIGITAL CONTENT MANAGER
Sarah Allidina
HEAD OF PRODUCTION
Natalia Rosek
DESIGN
Samuele Motta
Grant Chapman
Kellie Jerrard
PRODUCTION EDITOR
Benjamin Chiou
MANAGING EDITOR
Peter Archer
BUSINESS CULTURE FINANCE HEALTHCARE LIFESTYLE SUSTAINABILITY TECHNOLOGY INFOGRAPHICS http://raconteur.net/understanding-stroke-2016
CONTRIBUTORS
Although this publication is funded through advertising and
sponsorship,alleditorialiswithoutbiasandsponsoredfeatures
are clearly labelled. For an upcoming schedule, partnership in-
quiries orfeedback, please call +44 (0)20 8616 7400 ore-mail
info@raconteur.net
Raconteur is a leading publisher of special-interest content
and research. Its publications and articles cover a wide range
of topics, including business, finance, sustainability, health-
care, lifestyle and technology. Raconteur special reports are
published exclusively in The Times and The Sunday Times as well
as online at raconteur.net
The information contained in this publication has been ob-
tained from sources the Proprietors believe to be correct.
However, no legal liability can be accepted for any errors. No
part of this publication may be reproduced without the prior
consent of the Publisher. © Raconteur Media
Funding for research
could save many lives
Stroke cuts lives short and has devastating effects on
survivors, yet there is a desperate shortage of funding for
research into its prevention and rehabilitation of patients
OVERVIEW
DANNY BUCKLAND
Share this article online via
Raconteur.net
StrokeAssociation
Source:
Stroke Association,
State of the Nation
80%of strokes could
be prevented
PUBLISHED IN
ASSOCIATION WITH
RACONTEUR raconteur.net 03UNDERSTANDING STROKE06 / 04 / 2016
UNDERSTANDING
STROKE
Stroke Association
volunteers
supporting a
stroke survivor
334 x 96mm
RACONTEUR raconteur.net 05UNDERSTANDING STROKE06 / 04 / 2016
Gareth Beevers, professor of medi-
cine at the University of Birmingham
and a trustee of Blood Pressure UK,
says: “High blood pressure is by far the
most important risk factor for stroke.
In fact, when antihypertensive drugs
became widely available in the 1960s,
strokes were substantially reduced.”
In a review of 14 clinical trials in-
volving a total of 370,000 people with
high blood pressure, antihypertensive
drugs such as beta-blockers (heart
rate lowering medications) and diu-
retics (water pills) reduced strokes by
35 to 40 per cent.
However, other factors are at play.
Obesity, diabetes, high blood choles-
terol, lack of exercise, smoking and
excessive alcohol consumption all in-
crease the chances of having a stroke.
And these are greater for individuals
with atrial fibrillation (irregular heart-
beat) and people who have a family
history of stroke, or are of south-Asian
or African-Caribbean background.
As for increasing age, it’s worth
noting that, while strokes are more
likely among the elderly, one in four
affect people younger than 65, accord-
ing to the Stroke Association.
This plethora of risk factors means
blood pressure shouldn’t be consid-
ered in isolation, but in the context of
other patient characteristics, explains
Dr Nicholas Summerton, a GP in East
Yorkshire and former clinical adviser
in primary care diagnostics to the De-
partment of Health.
“A high reading matters more if, for
example, you have diabetes or are a
smoker. And a normal reading doesn’t
necessarily mean you are problem
free. It depends on your overall stroke
risk,” he says.
twelve months if their blood pressure
is borderline. The current recommen-
dation is that higher-than-normal
blood pressure should be brought
below 140 over 90. But the general con-
sensus is that interventions should be
more aggressive and aim for readings
below 120 over 80.”
Pippa Tyrrell, professor of stroke
medicine at the University of Manches-
ter, agrees and highlights the impor-
tance of monitoring approaches that
can help with this, such as ambulatory
blood pressure monitoring, whereby
patients are fitted
with an electronic
device that measures
their blood pressure
throughout the day
astheymovearound,
and self-monitoring
at home.
“They provide a
largeamountofdata
from readings taken
in the patient’s own
environment, helping with diagnosis
and treatment decisions,” says Pro-
fessor Tyrrell. Plus, evidence suggests
that home self-monitoring, which a
survey by the University of Birming-
ham estimates is already used by
about 30 per cent of UK hypertensive
patients, may improve health out-
comes.
In a study published in The Journal
of the American Medical Association,
by an Oxford University team headed
by Professor Richard McManus,
self-monitoring led to greater blood
pressure reductions than readings reg-
ularly taken by a doctor.
“Wearable technology can also
help with certain risk factors,”
says Dr Summerton. “For example,
pulse monitors can detect heart-
beat irregularities due to atrial fi-
brillation, which is associated with
a five-fold increased risk of stroke.
And fitness bands seem to encour-
age people to exercise more. But the
evidence supporting wearables’ ef-
ficacy is limited.”
So there really are effective ways to
control high blood pressure, address
other risk factors and, ultimately,
reduce the likelihood of a stroke.
And these same measures can help
those who have already had one.
Therefore, the majority of strokes
shouldn’t occur. As Professor
Beevers concludes: “They should be
almost a thing of the past.”
High blood
pressure is by
far the most
important risk
factor for stroke
Share this article online via
raconteur.net
Doctors can calculate a person’s
stroke risk using a computerised
tool (QRISK2) recommended by the
National Institute for Health and
Care Excellence, which provides na-
tional guidance on disease preven-
tion and treatment.
Thisenablestimely,personalisedpre-
vention. And prevention can save lives.
In a report on hypertension, Public
Health England says: “In ten years,
45,000 years of life could be saved,
and £850 million not spent on related
health and social care, if we achieved
a reduction in the
average population
blood pressure.”
But, achieving this
goal requires a col-
laborative effort. On
one hand, govern-
ment and health-
care commission-
ers and providers
must promote and
support preven-
tion. There are examples, such as the
Department of Health’s Change4Life
campaign, which encourages people
to eat healthy and exercise more, and
the NHS Health Check, a mid-life MOT
offered to everyone aged 40 to 74. On
the other hand, individuals must be
willing to embrace prevention.
The good news is there are effec-
tive ways of integrating prevention
in everyday life. Lucy Wilkinson,
senior cardiac nurse at the British
Heart Foundation, recommends
“reducing salt intake to less than
six grams per day, as this is directly
linked to hypertension; aiming for
at least 150 minutes of moderate-in-
tensity physical activity a week; and
losing excessive weight”.
She says: “Avoiding smoking and
excessive alcohol consumption is also
important. New guidance advises men
and women to drink no more than 14
units of alcohol a week, and to have at
least two or three alcohol-free days.”
People should also have regular
blood pressure checks. This is key to
the early detection and treatment of
hypertension, for the condition devel-
ops silently over many years, before
the first symptoms become obvious.
Ms Wilkinson points out: “Nearly
30 per cent of adults in the UK have
high blood pressure, but about half
– around seven million people
– are not receiving treatment be-
cause they don’t know they have
the condition.”
Professor Beevers adds: “Every adult
should have their blood pressure
checked every five years or every six to
It’s possible to make
strokes a thing of the past
Being aware of the risk factors and taking preventative measures can
greatly reduce the chances of becoming a victim of stroke
T
he key to reducing the
frighteningly high inci-
dence of stroke is taking
control of the modifiable
risk factors for the condition. And
number one of these factors is high
blood pressure or hypertension,
which is a contributing cause in
more than 50 per cent of strokes,
according to the Stroke Associa-
tion’s State of the Nation: stroke sta-
tistics report.
The NHS says that ideally blood
pressure should be below 120 over
80. . Readings above 140 over 90 are
considered hypertension. This puts
strain on blood vessels, increasing
the likelihood of strokes.
PREVENTION
LORENA TONARELLI
A stroke is when the blood
flow to part of the brain is cut
off or reduced. It is also known
as a “brain attack”.
When it happens, brain cells
no longer get the nutrients
and oxygen they need to
function and begin to die. This
can cause lasting damage to
the functions or parts of the
body the cells control. For
example, a stroke may result in
difficulties talking, swallowing,
moving one arm or walking.
There are two main types of
stroke: ischaemic stroke; and
haemorrhagic stroke.
Ischaemic strokes are the
most common, accounting
for about 85 per cent of
cases, according to the Stroke
Association’s State of the
Nation report. They occur when
a blood vessel that supplies the
brain becomes blocked. This
can happen because of a blood
clot that forms in the brain
(thrombotic stroke), or because
of a blood clot or air bubble
that forms around the body and
travels up to the brain (embolic
stroke). Ischaemic strokes
can also be caused by a fatty
material, called plaque, which
builds up inside blood vessels
reducing blood flow. This is
known as atherosclerosis.
Haemorrhagic strokes occur
when blood vessels in the brain
leak or burst causing bleeding.
In this case, brain cells die
because of the build-up of
pressure from the bleeding.
Haemorrhagic strokes can
happen inside the brain
(intracerebral haemorrhage)
or in the space between the
brain and the tissue that
protects it (subarachnoid
haemorrhage). They are rarer,
but generally more serious,
than ischaemic strokes.
WHAT IS STROKE?
Source: Stroke Association, State of the Nation
PREVALENCE OF HIGH BLOOD PRESSURE IN THE UK
PEOPLE REGISTERED AS HYPERTENSIVE
2005
11.4%
13.8%
13.9%
12%
12.6%
12.9%
13.2%
13.4%
13.6%
13.7%
2006 2007 2008 2009 2010 2011 2012 2013 2014
people in the UK are
registered as hypertensive;
an additional 6.8 million are
thought to be undiagnosed
9.2m+
Medfield Diagnostics is developing
a unique method to diagnose stroke
using microwave technology, which
is portable, safe and fast. The device
weighs 6 kg, uses less than 1% of
the power emitted by a mobile phone
And gives a diagnostic answer in less
than a minute. It is battery operated
and well suited to be used pre-
hospitally, at the scene of the incidence.
During an acute stroke,brain cells,
deprived of oxygen, die at a rate of two
million cells per minute.
The sooner treatment to restore oxygen
supply is applied the less brain damage
and a faster recovery for the patient. Fast
ambulance based diagnostics leads to
more options.
During a stroke, brain tissue dies due to lack of oxygen
The cause of a stroke was
known in the ambulance
- The time to treatment could be
shortened
- Patient suffering could be reduced
- More patients could be optimally treated
- Savings could be made in care and
rehab costs
Info@medfielddiagnostics.com | medfielddiagnostics.com | +46 31 160 668
What
If?
Early Diagnosis Opens up for
more possibilities
	
  
WHAT	
  IF?	
  
Stroke	
  origin	
  was	
  known	
  in	
  the	
  ambulance	
  
Time	
  to	
  treatment	
  could	
  be	
  shortened	
  
Patient	
  suffering	
  could	
  be	
  reduced	
  
More	
  patients	
  could	
  be	
  treated	
  optimally	
  
Savings	
  could	
  be	
  made	
  in	
  care	
  and	
  rehab	
  costs	
  
Medfield	
   Diagnostics	
   is	
   developing	
   a	
   unique	
   method	
   to	
   diagnose	
  
stroke	
  using	
  microwave	
  technology,	
  which	
  is	
  portable,	
  safe	
  and	
  fast.	
  
The	
  device	
  weighing	
  <	
  6	
  kg,	
  using	
  <	
  1%	
  of	
  the	
  emission	
  from	
  a	
  mobile	
  
phone	
  and	
  giving	
  a	
  diagnostic	
  answer	
  in	
  less	
  than	
  a	
  minute.	
  It	
  is	
  battery	
  
operated	
  and	
  well	
  suited	
  to	
  be	
  used	
  pre-­‐hospital,	
  at	
  the	
  scene	
  of	
  the	
  
incidence.	
  	
  
	
  
	
   	
  
During a stroke, brain tissue dies due to lack of oxygen
During an acute stroke, ca. 2 million brain cells die per minute. Faster treatment to restore oxygen
supply leads to less brain damage and a faster recovery for the patient. 85% of the stroke cases are
due to a clot and 15% are due to bleeding. Thrombolytic treatment is a proven efficient clot buster
but must be administered within 4.5 hours of the onset of the stroke to be effective and is
detrimental if administered to a patient suffering from a bleeding stroke. Due to this, the cause of the
stroke has to be determined before thrombolytic treatment can be administered. Today, the
differentiation is made using a CT or MR scan at the hospital, which means that the lead time from
onset of stroke to diagnosis often exceeds 4.5 hours. As a result, only 1-8% of stroke patients
receive this highly effective treatment
Early	
  Diagnosis	
  
Opens	
  up	
  for	
  more	
  possibilities	
  
Therapy	
  options	
  
Hospital	
  options	
  
Transport	
  options	
  
Therapy
options
Hospital
options
Transport
options
The dedication to drive patient care forward?
Do You Have
We are currently collaborating with research
oriented organisations who are interested in the
development of stroke and trauma care. Do you
want to join us?
UNDERSTANDING STROKE raconteur.net06 RACONTEUR RACONTEUR raconteur.net 07UNDERSTANDING STROKE06 / 04 / 2016 06 / 04 / 2016
Source:
World Stroke Organization
11.9%of all deaths
worldwide
are caused by
stroke
1in6people in the
world will
suffer a stroke
in their lifetime
TREATMENT RECORD
DANNY BUCKLAND
UK is playing catch-up to
improve stroke outcomes
The UK lags behind other developed nations in the league table of stroke treatment and, despite
some notable achievements, there remains much to do
L
ess than a decade ago, a dis-
turbing public health report
discovered that scanners
needed to diagnose stroke vic-
tims were kept under lock and key after
office hours. An antiquated service also
saw the technology positioned away
from Accident and Emergency depart-
ments making it difficult for doctors to
confirm their diagnosis.
Only 58 per cent of patients were
given a scan within 24 hours, while
at the Princess of Wales Hospital in
Grimsby, the report noted, the aver-
age weekday waiting time for scan-
ning results stretched to 48 hours
– and stroke is a condition that waits
for no man or woman.
The historical landscape of stroke
goes some way to explain the lethal
deficiencies in the service. The word
stroke only came into common med-
ical use in the 1960s, replacing the
term apoplexy – from a Greek deri-
vation meaning thunder struck – to
describe what seemed to be a sudden
and random affliction.
Rehabilitation from stroke was not
regularly featured in medical text-
books until the late-1950s, according
to the 1997 Age and Ageing report, as
understanding of what was then iden-
tified as a problem of internal bleed-
ing was still playing catch-up.
Stroke services in England were
officially graded as “poor” by the
National Audit Office (NAO) in 2005,
and a mammoth task of recalibrating
public awareness, facilities, staff and
delivery was instigated.
The campaign’s success is one of the
NHS’s towering achievements – death
rates have been almost halved in a
decade – but clinicians are still fearful
that life-saving and affirming treat-
ments are not getting to patients. Also
fresh government strategies could
unpick the hard-earned progress.
At the same time, figures from the
World Health Organization show the
UK still lags behind other, poorer na-
tions in crucial aspects of morbidity
and mortality.
Its Atlas of Heart Disease and Stroke
records 15 million strokes globally every
year, which leave five million dead and
five million with permanent disability.
The UK is positioned in the 10,000 to
99,999 bracket, denoting a death rate
higher than Scandinavia, Belgium,
Switzerland, Slovenia, Croatia, and
some Arab and African nations.
Some of the disparity can be ex-
plained by different national re-
porting methods, but the emerging
consensus is that the UK’s stroke
services still need to improve before
it can attain world-class status
across the treatment disciplines.
The government’s response to the
NAO 2005 shock was to give stroke
tier-1 importance and load it with
financial incentives, while the Royal
College of Physicians launched
the Sentinel Stroke National Audit
Programme to provide important
annual route markers of services.
“Both were important because,
if you don’t know where you are,
it is very difficult to tell when you
will reach your destination,” says
senior stroke consultant Damian
Jenkinson, whose unit at the Royal
Bournemouth Hospital was one
of the first in the country to offer
clot-busting thrombolysis treat-
ment around the clock, as well as
pioneering telemedicine to make
rapid treatment decisions.
“Major improvements have oc-
curred since the National Audit Office
declared that services were poor
quality and poor value for money.
They could see by looking at care
elsewhere on the planet that invest-
ing in certain parts of the pathway,
and getting people with acute stroke
into each stroke unit really quickly
was going to improve the care and be
efficient, effective and cheaper.”
Services and performance were re-
vitalised by setting up 28 stroke-spe-
cific networks, and the FAST – face,
arms, speech, time – acronym pub-
lic-awareness campaign to enable
swift recognition of the early symp-
toms of stroke gained traction.
But many experts feel the impetus
has stalled. “It has sort of gone off the
boil politically,” says Dr Jenkinson,
a former national clinical director
for stroke, who now works at Dorset
County Hospital. “We are getting to-
wards the end of the ten-year stroke
strategy and lots of other strategies
have landed on commissioners’
desks in the meantime. There is a
feeling in the stroke community that
the emphasis has waned.
“The Stroke Association is challeng-
ing the government to give the strat-
egy a refresh and have a new era in
stroke. It is a major challenge to finish
off this work, but it feels, at shop-floor
level, like there is a move to create
more generic units where stroke vic-
tims will be treated alongside hip frac-
tures and pneumonia patients.”
The contributory factors for stroke
are similar to heart attacks, namely
smoking, hypertension, atrial fibril-
lation and lifestyle-induced condi-
tions such as obesity and diabetes.
Drug therapies play a huge part in
treatment with new ranges of an-
ti-coagulants controlling blood flow
and minimising the risk of a block-
age to a cerebral artery.
But a significant blot on the na-
tion’s stroke service copybook is
in the patchy use of recent devel-
opments in mechanical thrombec-
tomy where a catheter is inserted,
normally via the groin, to guide a
stent to the site of a clot where it
can be grabbed and
removed quickly to
restore blood flow
to the brain.
Sanjeev Nayak, a
consultant neuro-
radiologist at Uni-
versity Hospitals
of North Midlands
NHS Trust, in Stoke,
who has pioneered
the technique since
2009, believes
thrombectomy can
be performed on up
to 15,000 patients with acute ischae-
mic stroke a year, saving lives and
reducing the level of disability for
stroke survivors.
“The main concern is about the
infrastructure – and the UK is way
behind Europe and the United
States when it comes to mechanical
thrombectomy,” he says. “Despite
the clinical evidence, less than 500
patients are treated annually within
the UK with mechanical thrombec-
tomy, when there are at least 8,000
to 15,000 eligible patients per year,
which in my opinion is scandalous.
This is due to lack of infrastructure
and funding issues.
“In contrast, some 9,000 patients
are treated in Germany. Developing
the infrastructure with appropriate
funding to deliver such a service in
the UK should be a priority.”
His case list includes some star-
tling results including a pregnant
It is almost as if
stroke has had
its day and the
spotlight has
switched to other
areas such as
cancer or dementia
27-year-old who was admitted in
March with paralysis down the
right side, and both her and the
baby’s future in the balance. Dr
Nayak was able to remove the clot
in a 15-minute procedure and the
woman walked from the hospital
with no ill-effects and the pregnan-
cy still viable.
Post-acute care is a key area
where services need to improve
through the early supported dis-
charge scheme that provides re-
habilitation at home for up to six
weeks. Government figures show 25
per cent of clinical commissioning
groups do not provide this.
“There is still a
feeling that people
get abandoned and
there aren’t enough
community support
teams,” adds Dr Jen-
kinson. “We man-
aged to reorganise
care delivery in 170
hospitals, but it is
proving harder to
deal with the 90,000
patients discharged
after stroke every
year. Follow-up is a
challenge and only a third of them
go for their six-month check-up.”
Marion Walker, professor in
stroke rehabilitation at the Uni-
versity of Nottingham, concludes:
“It is almost as if stroke has had its
day and the spotlight has switched
to other areas such as cancer or de-
mentia. However, the stark figures
tell the story: this is a condition
with high morbidity and mortality.
We still haven’t cracked it and there
is a gathering realisation of this and
the need to bring the spotlight back
on to stroke.
“There is life after stroke. It may
be different, but it can be a very
good life. People can still enjoy
their family, friends, hobbies and
get back to work. We have made
huge strides in the last couple of
decades and it has been a privilege
to be a part of that, but there is still
much to do.”
RUSSIA
MACEDONIA
GUYANA
BULGARIA
TURKMENISTAN
ROMANIA
PHILIPPINES
UKRAINE
LATVIA
KAZAKHSTAN
MONGOLIA
LITHUANIA
CROATIA
JAMAICA
SOUTHAFRICA
HUNGARY
SLOVAKIA
BRAZIL
TURKEY
GREECE
CUBA
POLAND
PORTUGAL
CHILE
KUWAIT
KOREA
ARGENTINA
UAE
NEWZEALAND
MEXICO
ITALY
SINGAPORE
JAPAN
EGYPT
IRELAND
UK
SWEDEN
GERMANY
BELGIUM
AUSTRALIA
NORWAY
BAHRAIN
HONGKONG
SPAIN
US
THAILAND
QATAR
CANADA
FRANCE
139.9
138.1
133.9
126.3
118.3
114.8
112.7
106.9
97.7
90.3
83
80.2
70.1
65.4
61.9
58.2
55.1
52.8
49.1
47.9
44.8
43.6
40.5
36.6
35.3
34.6
32
31.6
30.1
29.9
29.5
27.8
26.5
25.7
24.9
24.5
24.4
23.9
23.6
22.7
22.3
22
21.4
20.6
20.5
19.3
7.9
17.4
17.9
AUSTRIA20.8
GLOBAL MORTALITY RATES FROM CEREBROVASCULAR DISEASE*
AGE-STANDARDISED DEATH RATES PER 100,000, FOR SELECTED COUNTRIES
WITH LATEST AVAILABLE DATA
48-67
68-85
86-104
105-122
123-143
UK STROKE MORTALITY RATES
AGE-STANDARDISED DEATH RATES
FROM STROKE PER 100,000
AVERAGE MORTALITY RATES FROM CEREBROVASCULAR DISEASE, BY REGION*
AGE-STANDARDISED DEATH RATES PER 100,000; AVERAGES BASED ON SELECTED COUNTRIES WITH LATEST AVAILABLE DATA
TOP 10 LEADING CAUSES OF DEATH WORLDWIDE
BY NUMBER OF DEATHS IN MILLIONS
58.58
Africa
42.88
Europe
23.24
Middle East
18.95
North America
Source: British Heart Foundation 2015
Source: WHO
Source: WHO 2014
Source: WHO/Raconteur analysis
TOP 5HIGHEST AND LOWEST STROKE MORTALITY RATES IN THE UK
AGE-STANDARDISED DEATH RATES FROM STROKE DISEASE PER 100,000
Region
Northern Ireland
Northern Ireland
Scotland
Scotland
Yorkshire and The Humber
Region
East Midlands
East Anglia
London
South East
London
ASDR per 100,000
140.4
135.8
121.7
120.6
111.9
ASDR per 100,000
48.3
49
49.5
49.7
50.4
HIGHEST
Local authority
Ballymena
Cookstown
Renfrewshire
West Dunbartonshire
Scarborough
LOWEST
Local authority
South Northamptonshire
Babergh
Richmond upon Thames
Swale
Westminster
Source:
Stroke Association,
State of the Nation
13Every 13 minutes stroke
will take someone’s
life in the UK
7%of all deaths
in the UK are
caused by stroke
1.1
Hypertensive heart disease
1.3
Road injury
1.5
Diabetes
1.5
Diarrhoeal
diseases
1.5
HIV/Aids
1.6
Lung cancer
3.1
Lower
respiratory
infections
3.1
Chronic obstructive
pulmonary disease
7.4
Ischaemic
heart disease
6.7
Stroke
36.54
Latin America
38.19
Asia-Pacific
102.91
Former Soviet Union
*Global statistics are for cerebrovascular disease, a common cause of stroke
RACONTEUR raconteur.net 09UNDERSTANDING STROKE06 / 04 / 2016
floors of medical conferences” as
thrombectomy data is presented.
In a Canadian meta-analysis of
eight trials involving more than
2,400 patients presented in April
last year, for example, thrombec-
tomy was associated with much
improved functional outcomes at
90 days compared with standard
medical care using thrombolyt-
ics (44.6 per cent against 31.8 per
cent respectively).
How many patients will benefit
from thrombectomy in the UK is
still unclear, but Dr Webb says: “If
you are one of these patients, this
is absolutely life-transforming.”
In February, NICE updated guid-
ance backing thrombectomy, but a
full technology appraisal is needed
to get the mandate that would help
M
ajor strides have been
made in the understand-
ing of stroke in the last
fewyearswithsignificant
advances in imaging and medicines. In
particular, there are now four oral an-
ti-coagulants to prevent stroke in atri-
al fibrillation patients on the market.
However, the innovation causing
the biggest stir among stroke clini-
cians is thrombectomy, also known
as mechanical clot retrieval. The
technique involves inserting a cath-
eter into a large blood vessel, usual-
ly in the groin, and locating the clot
through a cerebral angiography; a
device is then inserted through the
catheter to pull the clot out.
At present, thrombolytics are
used to dissolve blood clots, but
these must be given within four-
and-a-half hours of the start of the
stroke and only benefit around one
in seven people treated, according
to the National Institute for Health
and Care Excellence (NICE).
Thrombectomy has impressed cli-
nicians treating patients with larger
clots, which are likely to lead to
greater disability due to blood flow
being interrupted for longer. Pro-
fessor Tony Rudd, national clinical
director for stroke with NHS Eng-
land, says the technique is “top of
the list” of recent innovations. “In
the last 15 months, we have had five
trials which have shown it is highly
effective,” he says.
His enthusiasm is shared by Dale
Webb, director of research and in-
formation at the Stroke Associa-
tion, who says that “over the last
year and a half, people have been
whooping and cheering on the
get the procedure routinely com-
missioned across the NHS.
Professor Rudd also notes that the
challenge is to get enough trained
interventional neuro-radiologists
to perform such highly skilled pro-
cedures. However, the cost of train-
ing staff and setting up dedicated
thrombectomy units is less than the
financial burden of having to treat
people with long-term disability
caused by stroke.
Another area causing excitement is
the use of stem cells to reverse some
of the disabling effects of stroke.
One of the leading lights in this
field is Professor Keith Muir of the
University of Glasgow’s Institute
of Neuroscience and Psychology,
who has been involved in a phase I
trial undertaken from 2009 to 2015
involving 11 people with disabling
long-term effects of stroke.
Different doses of cells were inject-
ed deep into the brain, close to the
location of the stroke damage. He
says: “We observed improvements in
various abilities in several patients,
which was interesting given how late
after the stroke we included people.”
Professor Muir stresses that the
study was not designed to demon-
strate efficacy, “so these intriguing
observations need to be further in-
vestigated”, he says. To this end, a
phase II study has been running at
a number of UK hospitals since mid-
2014, which aims to investigate the
recovery of arm function, and initial
data is expected to be reported in
around 20 patients this summer.
It is clearly early days, but Professor
Muir says: “In general, it is now be-
lieved that cell-therapy approaches
are probably acting by modifying the
body’s response to injury, stimulat-
ing recovery and reducing harmful
effects of inflammation.” The stud-
ies will give detailed information on
the safety and feasibility of deliver-
ing cells by injection into the brain
within a few months of a stroke.
A small study from Oxford’s Nuff-
ield Department of Clinical Neuro-
sciences found that patients who
were given electrical brain stimula-
tion alongside rehabilitation fared
better than those on rehab alone.
The trial, published in the Journal of
Science Translational Medicine, in-
volved 24 people who had strokes at
least six months previously and still
experienced difficulties moving their
hands and arms.
The recovery of function in long-
term patients is an important area, but
INNOVATIONS
KEVIN GROGAN
with stroke, time is very much of the
essence in limiting brain damage. Dr
Webb at the Stroke Association points
to a microwave helmet, developed
in Sweden by Medfield Diagnostics,
which is being trialled in ambulances
and could slash diagnosis times.
Professor Joanna Wardlaw, chair of
appliedneuroimagingandheadofneu-
roimaging sciences at Edinburgh Uni-
versity, believes the next big innovation
will be treatments for small-vessel or
lacunar stroke, which she says could
also have a big impact on dementia.
A lacunar stroke is caused by
damage to one of the small vessels
deep within the brain and accounts
for around one in four strokes. The
British Heart Foundation, which is
helping to fund a three-year trial led
by Professor Wardlaw, cites research-
ers who believe it could be an under-
lying cause of at least 40 per cent of
all dementias.
There is currently no approved
treatment for a lacunar stroke and
in the trial around 200 patients will
be treated with either cilostazol,
isosorbide mononitrate or both, two
drugs currently used to treat angina
and peripheral vascular disease. By
performing MRI scans on people
taking part in the trial, Professor
Wardlaw and colleagues will monitor
whether the drugs have an effect on
the small vessels of the brain.
Thrombectomy, stem cell ther-
apy and testing two old, and very
cheap, drugs that could help pre-
vent dementia following stroke are
promising developments with the
potential of saving lives and trans-
forming outcomes.
Breakthroughs in the
battle to beat stroke
Innovative new procedures and drugs are giving fresh hope for
stroke patients as clinical trials show encouraging results
Share this article online via
raconteur.net
Cell-therapy
approaches are
probably acting
by modifying the
body’s response to
injury, stimulating
recovery and
reducing harmful
effects of
inflammation
The innovation
causing the
biggest stir among
stroke clinicians is
thrombectomy, also
known as mechanical
clot retrieval
Corbis
01
Thrombectomy
performed
under cerebral
angiography on a
patient with stroke
symptoms at CHU
Bordeaux
02
Strokefinder
microwave helmet
prototype, devel-
oped by Medfield
Diagnostics and
Chalmers Univer-
sity of Technology,
has the potential
to cut diagnosis
times dramatically
02
01
RESEARCH SPENDING ON DIFFERENT DISEASES IN THE UK
Source: Stroke Association 2012
Cancer
Spending on research
by charities and
governmental organisations
left axis
Spending on
research per person
with the disease
right axis
Coronary
heart disease
Dementia Stroke
£600m
£500m
£400m
£300m
£200m
£100m
£0
£300
£250
£200
£150
£100
£50
£0
GunillaBrocker
1. Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous
t-PA vs. t-PA alone in stroke. N. Engl. J. Med. Jun 11 2015;372(24):2285-2295.
Indications, contraindications, warnings and instructions for use can be found in the
product labeling supplied with each device. CAUTION: Federal (U.S.A.) law restricts this
device to sale by or on the order of a physician.
© 2016 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together
are trademarks of Medtronic. All other brands are trademarks of a Medtronic company.
16-eu-solitaire-advert-en-306893
Positive Clinical Outcomes
(mRS 0-2)1
60%
SolitaireTM
Device
Utilization in
SWIFT PRIME1
100%BETTER BY
DESIGN.
BACKED BY
DATA.
SolitaireTM
Revascularization Device
0%
Symptomatic Intracerebral
Haemorrhage sICH1
UNDERSTANDING STROKE raconteur.net10 RACONTEUR06 / 04 / 2016 RACONTEUR raconteur.net 11UNDERSTANDING STROKE06 / 04 / 2016
COMMERCIAL FEATURE
RACONTEUR raconteur.net 2XXXXxx xx xxxx
COMMERCIAL FEATURE
CLINICAL RESULTS INCREASE CALLS
FOR NEW NHS STROKE TREATMENT
A procedure that mechanically removes a blood clot in stroke patients is achieving notable results and cutting care costs
T
he results of important
clinical trials, published in the
last 15 months, have shown
mechanical thrombectomy can
improve recovery from stroke and
have led to increased demands to
make it available on the NHS.
Using thrombectomy to remove
a blood clot causing an acute
ischaemic stroke was found to be
safe and effective by the recent
PISTE trial at 11 UK hospitals and
other studies in the United States
and Canada.
The PISTE findings, presented
at the International Stroke
Conference in Los Angeles last
month, showed that at three
months after the stroke, 20 per
cent more patients in the group
who had received thrombectomy
made a full neurological recovery
compared to the group getting
standard treatment alone.
The study, funded by the Stroke
Association and the National
Institute for Health Research,
adds to a growing body of clinical
research that the procedure is safe
and effective within the NHS.
Physicians can treat smaller
blockages causing strokes with
thrombolysis, but larger clots,
identified byCT scan and angiogram,
can benefit more from direct
intervention by a thrombectomy
which uses a stent procedure to
remove the clot from harm’s way.
Time is a crucial factor with a target
to start operating of four-and-a-
half hours or less from onset.
Pioneering consultant
neuroradiologist Dr Sanjeev Nayak
believes more widespread use of
thrombectomy is imperative to save
lives and realise substantial savings
to the NHS and social care budgets.
His unit at the University
Hospitals of North Midlands NHS
Trust (UHNM), in Stoke-on-Trent,
Staffordshire, was the first to
introduce the procedure routinely
in 2009 and has performed more
thrombectomies than any other
hospital in the UK.
“Prior to using mechanical
thrombectomy, it was thrombolysis
where you give a clot-busting drug,”
he says. “But it worked in less than
10 per cent of patients whose main
artery to the brain was occluded
by a large clot. These patients with
large strokes would either die or
survive with a severe disability often
requiring 24/7 care throughout
their lives.
“With these advances we can pull
out the clot and immediately open
the vessel, and not have to wait for
a drug to dissolve it.
“We have had patients who have
come in with no movement at all
being able to walk out of the hospital
two days later. The benefits clinically
and financially are notable.”
A cost analysis based on 200
patients treated between 2010 and
2014 at UHNM demonstrated that
the hospital had saved £3.2 million
by freeing up bed space and a further
£16 million from social care budgets.
“The big problem is that patients
are not aware of this service and
the time limits,” says Dr Nayak,
who has contributed data to the
National Institute for Health and
Care Excellence (NICE), which
is currently conducting a health
economic review of thrombectomy
procedures. “We are saving lives
immediately, but there is no
infrastructure to support it. We need
a rapid-response ambulance service
and 24-hour cover. This needs to be
a round-the-clock service.
“The NHS spends £8.9 billion
a year treating strokes and we
have the potential to save billions
from that cost if this service is
done properly. It can make a big
difference to people’s lives but it
needs investment.
“We have calculated that around
8,000 to 30,000 patients a year
could benefit from this and, even
if you reach less than 50 per cent
of them, you are still saving 10,000
lives a year which is incredible.”
Christine Roffe, a stroke
physician at the Royal Stoke
University Hospital and professor of
stroke medicine at Keele University,
believes the trials’ evidence points
clearly towards thrombectomy
becoming a standard feature of
future NHS treatment.
“The evidence is now
uncontroversial that thrombectomy
is more effective than thrombolysis
when it can be given,” she says. “It
is a better treatment and allows the
patients to recover. The ‘number
needed to treat’ (NNT) to save
one patient from a long-term
dependence life is three to seven,
which is very low. The NHS normally
pays for anything with a NNT of 40
or below.”
Thrombectomies are more
expensive than thrombolysis as they
require a full neurointerventional
team, but at around £10,000 they still
offer cost benefits because patients
can return to full lives without social
care, says Professor Roffe.
“We are still waiting for the formal
health-cost analysis and NICE
commissioning guidelines, and we
will have to look at the infrastructure
so we can implement it, but I believe
it could be established quickly once
we have the political determination,”
she adds.
Clinicians want to see a series of
ten to fifteen regional centres of
excellence where interventionists
can stay in practice to maintain high
levels of success.
www.stryker.com
With these advances
we can pull out the clot
and immediately open
the vessel, and not have
to wait for a drug to
dissolve it
At Stryker Neurovascular, our
approach to Complete Stroke
Care centres on a culture of
innovation and partnerships,
from introducing
breakthrough technologies
and investigating leading-
edge therapies, to providing
ongoing training and
improving reimbursement. A
recognised leader in ongoing
innovation for the treatment
of ischemic and hemorrhagic
stroke, Stryker Neurovascular
is committed to delivering
a full spectrum of advanced
products for Complete Stroke
Care. Through research
and development of game-
changing technologies, we are
dedicated to real innovation
with a purpose.
COMPLETE STROKE CARE®
Gaming tech can beat patchy provision
Stroke survivors face a postcode lottery when it comes to rehabilitation services, but a version of gaming
technology may provide the answer to improving at-home therapy
W
hile acute care of stroke
patients in many parts
of England and Wales
is now world class, the
long-term support and rehabilitation
of stroke survivors is lagging behind.
Inaclinicalauditofpost-strokeservice
providers, published in December, it is
described as “very patchy”.
The audit, by the Royal College of
Physicians on behalf of the Intercol-
legiate Stroke Working Party, points
out that psychological support for
those who suffer what is often a
life-changing event is as important
as physical support. But it found the
median waiting time for patients
needing such support was ten weeks,
with around 25 per cent having to
wait five months or longer.
Alexis Wieroniey, the Stroke Associ-
ation’s deputy director for policy and
influencing, says: “The improvements
we’ve seen in emergency care are not
being matched in rehabilitation. Even
in hospital, stroke survivors don’t
always get the amount of rehab thera-
py they should.”
According to the Stroke Association’s
State of the Nation: stroke statistics
report, around 45 per cent of stroke
survivors are left with swallowing diffi-
culties, putting them at risk of choking
on small pieces of food. Speech and
language therapists are trained to help
them, and under National Institute for
Health and Clinical Excellence (NICE)
guidelines they should have 45 min-
utes of this therapy every day.
On average, according to a stroke
clinical audit published in Janu-
ary, they only get 41.9 per cent of the
speech and language therapy recom-
mended. Access to physiotherapy
and occupational therapy (OT) while
they are in hospital is better, with
stroke survivors getting 74.5 per cent
of the physiotherapy they should and
around 80 per cent of OT.
The principal reason stroke survi-
vors do not always get the amount
of rehab therapy they need is
staff shortages.
One way to address shortfall in
physiotherapy provision would be
the introduction of online thera-
py, enabling patients with moder-
ate-to-mild disability to play inter-
active computer games to help them
regain movement.
A company called EMVIGR has set
up a cloud-based platform that would
enable recovering stroke patients, in
hospital,athomeoronholidayabroad,
to access interactive online games that
involve them carrying out a range of
upper-limb movements.
The company, established by New-
castle University academics Janet
Eyre, professor of paediatric neurosci-
ence, and Dr Graham Morgan, a com-
puting scientist, with funding from the
Health Innovation Challenge Fund, is
awaiting final approval for its system
from the Medicines and Healthcare
products Regulatory Agency, and is in
talks with the NHS.
Professor Eyre says: “We’re keen to
get this out to patients and are talk-
ing to the distributors who market
products to NHS hospitals. We’ve
also had approaches from India,
China and Australia, and are opti-
mistic that by the end of this year
we’ll have signed contracts.”
Six different games have been
tested. Professor Eyre envisages that
after playing the games in hospital,
stroke survivors will continue playing
at home on their PC or laptop for a
small licence fee.
She says: “We know that the bigger
the dose of physiotherapy a stroke
patient gets the better the outcome.
While the patient may get one-to-
one physiotherapy in hospital, at
home they have to do exercises by
themselves. They often find this
boring, but when they play a com-
puter game they get engaged and
reward hormones kick in.
“Progress is assessed remotely
by a therapist, who can e-mail or
phone the patient when it is time
for them to move on to a more dif-
ficult game.”
Every year in the UK around 26,000
stroke survivors are left with some kind
of long-term facial paralysis. Often
they are simply given an A4 sheet of
exercises to do in front of a mirror.
Philip Breedon, professor of smart
technology at Nottingham Trent Uni-
versity,believesthisisabouttochange.
In a project funded by the Nation-
al Institute for Health Research in-
vention for innovation programme,
Professor Breedon and his team have
used gesture recognition sensors
from gaming technology to develop a
“face-to-face” system for patients to
use at home.
“The beauty of this technology
is that it allows the exercises to be
tailored to the needs of the indi-
vidual patient, and changed if and
when necessary. Both patients and
therapists like it, and our aim is for
it to be used in clinical practice,”
he says.
REHABILITATION
JUDY HOBSON
“In July, a trial will follow the pro-
gress of 80 stroke patients with facial
paralysis for the next two years.
Patients will get feedback on their
screens to allow them to see how
they’re doing, and a speech and lan-
guage therapist will be able to com-
municate remotely with them and
check their progress.
“We hope this will lead to it becom-
ing commercially available and being
taken up by the NHS.”
Penny Standen, professor of health
psychology and learning disabilities
at Nottingham University, has been
evaluating home-based gaming inter-
ventions for stroke rehabilitation.
She says: “I would say we’re three
quarters of the way there. The big
question is who will pay. NICE will
want a high level of evidence to show
they’re effective before recommend-
ing use on the NHS.
“Their big advantage is that they’re
consistent, don’t get fed up with you
making mistakes, don’t get distracted
and don’t get bored, and allow people
to do exercises whenever they want. I
see them as complementary to tradi-
tional therapy.”
Share this article online via
raconteur.net
The principal
reason stroke
survivors do not
always get the
amount of rehab
therapy they need
is staff shortages
NottinghamTrentUniversity
Video gaming
technology is used
to help patients
left with facial
paralysis after
a stroke
EFFECTS OF STROKE
PERCENTAGE OF STROKE PATIENTS AFFECTED
Source: Stroke Association, State of the Nation
33%
Bowel
control
33%
Depression
33%
Aphasia
45%
Swallowing
50%
Bladder control
50%
Slurred speech
54%
Facial weakness
60%
Visual problems
72%
Lower limb/
leg weakness
77%
Upper limb/
arm weakness
US-V7 (1)

Weitere ähnliche Inhalte

Was ist angesagt?

A less-invasive-approach-of-medial-meniscectomy-in-rat-a-model-to-target-earl...
A less-invasive-approach-of-medial-meniscectomy-in-rat-a-model-to-target-earl...A less-invasive-approach-of-medial-meniscectomy-in-rat-a-model-to-target-earl...
A less-invasive-approach-of-medial-meniscectomy-in-rat-a-model-to-target-earl...science journals
 
2015 Report: Medicines in Development for Heart Disease & Stroke
2015 Report: Medicines in Development for Heart Disease & Stroke2015 Report: Medicines in Development for Heart Disease & Stroke
2015 Report: Medicines in Development for Heart Disease & StrokePhRMA
 
Death By Medicine
Death By MedicineDeath By Medicine
Death By MedicineRay Gebauer
 
Managing comorbidities in heart failure
Managing comorbidities in heart failureManaging comorbidities in heart failure
Managing comorbidities in heart failureashwani mehta
 
Hiv & the heart
Hiv & the heartHiv & the heart
Hiv & the heartjameshakim
 
Degree of Suspicion of Peripheral Artery Disease among Geriatrics and Policem...
Degree of Suspicion of Peripheral Artery Disease among Geriatrics and Policem...Degree of Suspicion of Peripheral Artery Disease among Geriatrics and Policem...
Degree of Suspicion of Peripheral Artery Disease among Geriatrics and Policem...Jan Igor Galinato
 
2016 Report: Medicines in Development for Alzheimer's Disease
2016 Report: Medicines in Development for Alzheimer's Disease2016 Report: Medicines in Development for Alzheimer's Disease
2016 Report: Medicines in Development for Alzheimer's DiseasePhRMA
 
MEDICAL ETHICS AND CONFLICT OF INTEREST IN SCIENTIFIC MEDICINE
MEDICAL ETHICS AND CONFLICT OF INTEREST IN SCIENTIFIC MEDICINEMEDICAL ETHICS AND CONFLICT OF INTEREST IN SCIENTIFIC MEDICINE
MEDICAL ETHICS AND CONFLICT OF INTEREST IN SCIENTIFIC MEDICINEhome
 
International Society of Hypertension 2020 guidlines
International Society of Hypertension 2020 guidlinesInternational Society of Hypertension 2020 guidlines
International Society of Hypertension 2020 guidlinesJAFAR ALSAID
 
Introduction to ncd, coronary heart disease online lecture slides 2020 april 1
Introduction to ncd, coronary heart disease online lecture slides 2020 april 1Introduction to ncd, coronary heart disease online lecture slides 2020 april 1
Introduction to ncd, coronary heart disease online lecture slides 2020 april 1Animesh Jain
 
The Hidden Risk That Is Tearing Your Company Apart Acbg 3 30 10
The Hidden Risk That Is Tearing Your Company Apart   Acbg 3 30 10The Hidden Risk That Is Tearing Your Company Apart   Acbg 3 30 10
The Hidden Risk That Is Tearing Your Company Apart Acbg 3 30 10leanhealthguru
 
Stroke epidemiology and prevention ppt slides 2020 april 3
Stroke   epidemiology and prevention ppt slides 2020 april 3Stroke   epidemiology and prevention ppt slides 2020 april 3
Stroke epidemiology and prevention ppt slides 2020 april 3Animesh Jain
 

Was ist angesagt? (19)

A less-invasive-approach-of-medial-meniscectomy-in-rat-a-model-to-target-earl...
A less-invasive-approach-of-medial-meniscectomy-in-rat-a-model-to-target-earl...A less-invasive-approach-of-medial-meniscectomy-in-rat-a-model-to-target-earl...
A less-invasive-approach-of-medial-meniscectomy-in-rat-a-model-to-target-earl...
 
WCIM poster 2016, Bali
WCIM poster 2016, BaliWCIM poster 2016, Bali
WCIM poster 2016, Bali
 
Cardio Vascular Health challenges in presenting century
Cardio Vascular Health challenges in presenting century Cardio Vascular Health challenges in presenting century
Cardio Vascular Health challenges in presenting century
 
2015 Report: Medicines in Development for Heart Disease & Stroke
2015 Report: Medicines in Development for Heart Disease & Stroke2015 Report: Medicines in Development for Heart Disease & Stroke
2015 Report: Medicines in Development for Heart Disease & Stroke
 
Death By Medicine
Death By MedicineDeath By Medicine
Death By Medicine
 
Coronary Artery Disease in HIV
Coronary Artery Disease in HIVCoronary Artery Disease in HIV
Coronary Artery Disease in HIV
 
Managing comorbidities in heart failure
Managing comorbidities in heart failureManaging comorbidities in heart failure
Managing comorbidities in heart failure
 
Hiv & the heart
Hiv & the heartHiv & the heart
Hiv & the heart
 
Cvd n hiv
Cvd n hivCvd n hiv
Cvd n hiv
 
HIV associated cardiomyopathy
HIV associated cardiomyopathyHIV associated cardiomyopathy
HIV associated cardiomyopathy
 
Degree of Suspicion of Peripheral Artery Disease among Geriatrics and Policem...
Degree of Suspicion of Peripheral Artery Disease among Geriatrics and Policem...Degree of Suspicion of Peripheral Artery Disease among Geriatrics and Policem...
Degree of Suspicion of Peripheral Artery Disease among Geriatrics and Policem...
 
Ojchd.000527
Ojchd.000527Ojchd.000527
Ojchd.000527
 
2016 Report: Medicines in Development for Alzheimer's Disease
2016 Report: Medicines in Development for Alzheimer's Disease2016 Report: Medicines in Development for Alzheimer's Disease
2016 Report: Medicines in Development for Alzheimer's Disease
 
Ojchd.000524
Ojchd.000524Ojchd.000524
Ojchd.000524
 
MEDICAL ETHICS AND CONFLICT OF INTEREST IN SCIENTIFIC MEDICINE
MEDICAL ETHICS AND CONFLICT OF INTEREST IN SCIENTIFIC MEDICINEMEDICAL ETHICS AND CONFLICT OF INTEREST IN SCIENTIFIC MEDICINE
MEDICAL ETHICS AND CONFLICT OF INTEREST IN SCIENTIFIC MEDICINE
 
International Society of Hypertension 2020 guidlines
International Society of Hypertension 2020 guidlinesInternational Society of Hypertension 2020 guidlines
International Society of Hypertension 2020 guidlines
 
Introduction to ncd, coronary heart disease online lecture slides 2020 april 1
Introduction to ncd, coronary heart disease online lecture slides 2020 april 1Introduction to ncd, coronary heart disease online lecture slides 2020 april 1
Introduction to ncd, coronary heart disease online lecture slides 2020 april 1
 
The Hidden Risk That Is Tearing Your Company Apart Acbg 3 30 10
The Hidden Risk That Is Tearing Your Company Apart   Acbg 3 30 10The Hidden Risk That Is Tearing Your Company Apart   Acbg 3 30 10
The Hidden Risk That Is Tearing Your Company Apart Acbg 3 30 10
 
Stroke epidemiology and prevention ppt slides 2020 april 3
Stroke   epidemiology and prevention ppt slides 2020 april 3Stroke   epidemiology and prevention ppt slides 2020 april 3
Stroke epidemiology and prevention ppt slides 2020 april 3
 

Andere mochten auch

Expo Money São Paulo (17 a 19-09-2009)
Expo Money São Paulo (17 a 19-09-2009)Expo Money São Paulo (17 a 19-09-2009)
Expo Money São Paulo (17 a 19-09-2009)CPFL RI
 
Contenido carpeta b1 tercero de la est 119
Contenido carpeta b1  tercero de la est 119Contenido carpeta b1  tercero de la est 119
Contenido carpeta b1 tercero de la est 119Mildred Muñoz Florio
 
Apresentação Resultados 4T05
Apresentação Resultados 4T05Apresentação Resultados 4T05
Apresentação Resultados 4T05CPFL RI
 
Momentos Grado Once
Momentos Grado OnceMomentos Grado Once
Momentos Grado Oncersarco.red
 
Historia de la
Historia de laHistoria de la
Historia de lajonatan45
 
future-of-outsourcing
future-of-outsourcingfuture-of-outsourcing
future-of-outsourcingSenem Boyaci
 
Revista Eletrônica para Residentes/ Conselho Editorial: Estruturação e Funcio...
Revista Eletrônica para Residentes/ Conselho Editorial: Estruturação e Funcio...Revista Eletrônica para Residentes/ Conselho Editorial: Estruturação e Funcio...
Revista Eletrônica para Residentes/ Conselho Editorial: Estruturação e Funcio...Urovideo.org
 
Indicador de Vendas e Inadimplência, fevereiro de 2011
Indicador de Vendas e Inadimplência, fevereiro de 2011Indicador de Vendas e Inadimplência, fevereiro de 2011
Indicador de Vendas e Inadimplência, fevereiro de 2011SPC Brasil
 
Gestion de calidad
Gestion de calidadGestion de calidad
Gestion de calidadvictormejias
 
NEFRECTOMIA PARCIAL: DUPLICAÇÃO DA TÉCNICA ABERTA
NEFRECTOMIA PARCIAL: DUPLICAÇÃO DA TÉCNICA ABERTANEFRECTOMIA PARCIAL: DUPLICAÇÃO DA TÉCNICA ABERTA
NEFRECTOMIA PARCIAL: DUPLICAÇÃO DA TÉCNICA ABERTAUrovideo.org
 
Casilla de verificacion[1]..
Casilla de verificacion[1]..Casilla de verificacion[1]..
Casilla de verificacion[1]..camilayangelica34
 
Demonstrativo financeiro outubro 2012
Demonstrativo financeiro outubro 2012Demonstrativo financeiro outubro 2012
Demonstrativo financeiro outubro 2012Andy Castro
 
Apresentação Resultados 3T06
Apresentação Resultados 3T06Apresentação Resultados 3T06
Apresentação Resultados 3T06CPFL RI
 

Andere mochten auch (20)

Expo Money São Paulo (17 a 19-09-2009)
Expo Money São Paulo (17 a 19-09-2009)Expo Money São Paulo (17 a 19-09-2009)
Expo Money São Paulo (17 a 19-09-2009)
 
Caso practico
Caso practicoCaso practico
Caso practico
 
Contenido carpeta b1 tercero de la est 119
Contenido carpeta b1  tercero de la est 119Contenido carpeta b1  tercero de la est 119
Contenido carpeta b1 tercero de la est 119
 
Apresentação Resultados 4T05
Apresentação Resultados 4T05Apresentação Resultados 4T05
Apresentação Resultados 4T05
 
Livros Que Ja Li
Livros Que Ja LiLivros Que Ja Li
Livros Que Ja Li
 
Momentos Grado Once
Momentos Grado OnceMomentos Grado Once
Momentos Grado Once
 
Historia de la
Historia de laHistoria de la
Historia de la
 
Endnote web - EESC janeiro de 2013
Endnote web - EESC janeiro de 2013Endnote web - EESC janeiro de 2013
Endnote web - EESC janeiro de 2013
 
Problemas de razonamiento
Problemas de razonamientoProblemas de razonamiento
Problemas de razonamiento
 
Quien Soy
Quien  SoyQuien  Soy
Quien Soy
 
future-of-outsourcing
future-of-outsourcingfuture-of-outsourcing
future-of-outsourcing
 
Revista Eletrônica para Residentes/ Conselho Editorial: Estruturação e Funcio...
Revista Eletrônica para Residentes/ Conselho Editorial: Estruturação e Funcio...Revista Eletrônica para Residentes/ Conselho Editorial: Estruturação e Funcio...
Revista Eletrônica para Residentes/ Conselho Editorial: Estruturação e Funcio...
 
Indicador de Vendas e Inadimplência, fevereiro de 2011
Indicador de Vendas e Inadimplência, fevereiro de 2011Indicador de Vendas e Inadimplência, fevereiro de 2011
Indicador de Vendas e Inadimplência, fevereiro de 2011
 
Gestion de calidad
Gestion de calidadGestion de calidad
Gestion de calidad
 
Trabajo
TrabajoTrabajo
Trabajo
 
NEFRECTOMIA PARCIAL: DUPLICAÇÃO DA TÉCNICA ABERTA
NEFRECTOMIA PARCIAL: DUPLICAÇÃO DA TÉCNICA ABERTANEFRECTOMIA PARCIAL: DUPLICAÇÃO DA TÉCNICA ABERTA
NEFRECTOMIA PARCIAL: DUPLICAÇÃO DA TÉCNICA ABERTA
 
Casilla de verificacion[1]..
Casilla de verificacion[1]..Casilla de verificacion[1]..
Casilla de verificacion[1]..
 
Demonstrativo financeiro outubro 2012
Demonstrativo financeiro outubro 2012Demonstrativo financeiro outubro 2012
Demonstrativo financeiro outubro 2012
 
Silvia schmelkes
Silvia schmelkesSilvia schmelkes
Silvia schmelkes
 
Apresentação Resultados 3T06
Apresentação Resultados 3T06Apresentação Resultados 3T06
Apresentação Resultados 3T06
 

Ähnlich wie US-V7 (1)

Dag Andersson - CEO Diaverum, Chronic Diseases: The Everyday Epidemic
Dag Andersson - CEO Diaverum,  Chronic Diseases: The Everyday EpidemicDag Andersson - CEO Diaverum,  Chronic Diseases: The Everyday Epidemic
Dag Andersson - CEO Diaverum, Chronic Diseases: The Everyday EpidemicMarc Michel
 
Dr Debbie Lowe - The future of innovation in AF and stroke prevention
Dr Debbie Lowe - The future of innovation in AF and stroke preventionDr Debbie Lowe - The future of innovation in AF and stroke prevention
Dr Debbie Lowe - The future of innovation in AF and stroke preventionInnovation Agency
 
ANTICOAGULATE CAMPAIGN CLINICIANS TOOLKIT - BOOKLET SINGLE PAGE
ANTICOAGULATE CAMPAIGN CLINICIANS TOOLKIT - BOOKLET SINGLE PAGEANTICOAGULATE CAMPAIGN CLINICIANS TOOLKIT - BOOKLET SINGLE PAGE
ANTICOAGULATE CAMPAIGN CLINICIANS TOOLKIT - BOOKLET SINGLE PAGEJo Jerrome
 
Sackett bmj 1994 what measures of efficacy should journal articles provide bu...
Sackett bmj 1994 what measures of efficacy should journal articles provide bu...Sackett bmj 1994 what measures of efficacy should journal articles provide bu...
Sackett bmj 1994 what measures of efficacy should journal articles provide bu...Alejandro Mateo
 
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...Erwin Chiquete, MD, PhD
 
Cardiovascular Health - Final
Cardiovascular Health - FinalCardiovascular Health - Final
Cardiovascular Health - FinalCarlo Ammendolia
 
Healthcare 2.0 - The State of Healthcare, Trends and Future Developments
Healthcare 2.0 - The State of Healthcare, Trends and Future DevelopmentsHealthcare 2.0 - The State of Healthcare, Trends and Future Developments
Healthcare 2.0 - The State of Healthcare, Trends and Future DevelopmentsNick van Terheyden
 
Greater awareness of risk factors and early diagnosis can cut cancer toll
Greater awareness of risk factors and early diagnosis can cut cancer tollGreater awareness of risk factors and early diagnosis can cut cancer toll
Greater awareness of risk factors and early diagnosis can cut cancer tollLorena Tonarelli M.Sc.
 
PCNA eNews_September 2014
PCNA eNews_September 2014PCNA eNews_September 2014
PCNA eNews_September 2014Rolando Kahn
 
Bill Faloon at DaVinci 50 about stroke risk and blood pressure
Bill Faloon at DaVinci 50 about stroke risk and blood pressureBill Faloon at DaVinci 50 about stroke risk and blood pressure
Bill Faloon at DaVinci 50 about stroke risk and blood pressuremaximuspeto
 
The best health news over the last decade
The best health news over the last decadeThe best health news over the last decade
The best health news over the last decadeJA Larson
 
geographyalltheway.com - IB Geography - Food and Health - Prevention or Trea...
geographyalltheway.com - IB Geography - Food and Health -  Prevention or Trea...geographyalltheway.com - IB Geography - Food and Health -  Prevention or Trea...
geographyalltheway.com - IB Geography - Food and Health - Prevention or Trea...Richard Allaway
 
CIR.0000000000000921.pdf
CIR.0000000000000921.pdfCIR.0000000000000921.pdf
CIR.0000000000000921.pdfcikKahadi
 
Presentation on Ischemic Heart Disease
Presentation on Ischemic Heart DiseasePresentation on Ischemic Heart Disease
Presentation on Ischemic Heart DiseasePratikshya kisiju
 

Ähnlich wie US-V7 (1) (20)

CVD 15
CVD 15CVD 15
CVD 15
 
Dag Andersson - CEO Diaverum, Chronic Diseases: The Everyday Epidemic
Dag Andersson - CEO Diaverum,  Chronic Diseases: The Everyday EpidemicDag Andersson - CEO Diaverum,  Chronic Diseases: The Everyday Epidemic
Dag Andersson - CEO Diaverum, Chronic Diseases: The Everyday Epidemic
 
Addressing the global stroke burden
Addressing the global stroke burdenAddressing the global stroke burden
Addressing the global stroke burden
 
Dr Debbie Lowe - The future of innovation in AF and stroke prevention
Dr Debbie Lowe - The future of innovation in AF and stroke preventionDr Debbie Lowe - The future of innovation in AF and stroke prevention
Dr Debbie Lowe - The future of innovation in AF and stroke prevention
 
ANTICOAGULATE CAMPAIGN CLINICIANS TOOLKIT - BOOKLET SINGLE PAGE
ANTICOAGULATE CAMPAIGN CLINICIANS TOOLKIT - BOOKLET SINGLE PAGEANTICOAGULATE CAMPAIGN CLINICIANS TOOLKIT - BOOKLET SINGLE PAGE
ANTICOAGULATE CAMPAIGN CLINICIANS TOOLKIT - BOOKLET SINGLE PAGE
 
Sackett bmj 1994 what measures of efficacy should journal articles provide bu...
Sackett bmj 1994 what measures of efficacy should journal articles provide bu...Sackett bmj 1994 what measures of efficacy should journal articles provide bu...
Sackett bmj 1994 what measures of efficacy should journal articles provide bu...
 
Sustainable Healthcare - FT Report April 2015
Sustainable Healthcare - FT Report April 2015Sustainable Healthcare - FT Report April 2015
Sustainable Healthcare - FT Report April 2015
 
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
 
Cardiovascular Health - Final
Cardiovascular Health - FinalCardiovascular Health - Final
Cardiovascular Health - Final
 
Healthcare 2.0 - The State of Healthcare, Trends and Future Developments
Healthcare 2.0 - The State of Healthcare, Trends and Future DevelopmentsHealthcare 2.0 - The State of Healthcare, Trends and Future Developments
Healthcare 2.0 - The State of Healthcare, Trends and Future Developments
 
Cancer 2014: Why do we need a focus on value?
Cancer 2014: Why do we need a focus on value?Cancer 2014: Why do we need a focus on value?
Cancer 2014: Why do we need a focus on value?
 
Greater awareness of risk factors and early diagnosis can cut cancer toll
Greater awareness of risk factors and early diagnosis can cut cancer tollGreater awareness of risk factors and early diagnosis can cut cancer toll
Greater awareness of risk factors and early diagnosis can cut cancer toll
 
PCNA eNews_September 2014
PCNA eNews_September 2014PCNA eNews_September 2014
PCNA eNews_September 2014
 
Dec14
Dec14Dec14
Dec14
 
Bill Faloon at DaVinci 50 about stroke risk and blood pressure
Bill Faloon at DaVinci 50 about stroke risk and blood pressureBill Faloon at DaVinci 50 about stroke risk and blood pressure
Bill Faloon at DaVinci 50 about stroke risk and blood pressure
 
The best health news over the last decade
The best health news over the last decadeThe best health news over the last decade
The best health news over the last decade
 
All About Lung Cancer
All  About Lung Cancer All  About Lung Cancer
All About Lung Cancer
 
geographyalltheway.com - IB Geography - Food and Health - Prevention or Trea...
geographyalltheway.com - IB Geography - Food and Health -  Prevention or Trea...geographyalltheway.com - IB Geography - Food and Health -  Prevention or Trea...
geographyalltheway.com - IB Geography - Food and Health - Prevention or Trea...
 
CIR.0000000000000921.pdf
CIR.0000000000000921.pdfCIR.0000000000000921.pdf
CIR.0000000000000921.pdf
 
Presentation on Ischemic Heart Disease
Presentation on Ischemic Heart DiseasePresentation on Ischemic Heart Disease
Presentation on Ischemic Heart Disease
 

US-V7 (1)

  • 1. Despite notable achievements, there remains much to do FUNDING FOR RESEARCH COULD SAVE MANY LIVES THE UK IS PLAYING STROKE CATCH-UP GAMING TECH AIDS RECOVERY BREAKTHROUGHS IN STROKE BATTLE Innovative procedures and drugs are giving new hopeThere is a desperate shortage of funding for stroke research Gaming technology can improve at-home therapy 03 06 09 11 06 / 04 / 2016INDEPENDENT PUBLICATION BY #0370raconteur.net UNDERSTANDING STROKE
  • 2. I t strikes every three-and-a- half minutes with devastating results. Victims can be left se- verely disabled with lifelong care needs while one in eight strokes results in death within 30 days. Shifting age demographics and lifestyles mean we are living longer with more chronic illness, and al- though stroke is a spectre of old age, its potential to take and devastate lives still ranks lowly in terms of pub- lic perception and research funding. The public is thought to fear can- cer, heart disease and dementia way above stroke. It is a discon- certing view that can dilute fund- raising and delay vital research into an event that happens 152,000 times a year in the UK, according to the Stroke Association’s State of the Nation: stroke statistics report. “Stroke is one of the biggest health issues people face today and it will take a life every 13 min- utes,” says Jim Swindells, direc- tor of fundraising at the Stroke Association charity. “It is also the leading cause of complex adult dis- ability in the UK, and that can be devastating for the survivor and their loved ones.” Stroke costs the nation an estimat- ed £9 billion a year in health and so- cial costs, but its funding is dwarfed by other conditions. A massive £544 million (64 per cent) of the £856 mil- lion spent on research in 2012 went to cancer, while coronary heart disease benefitted to the tune of £166 million, but stroke trailed with £56 million. Stroke incidence rates fell 19 per cent from 1990 to 2010 through improved services, according to a report in The Lancet. But an ageing population, combined with long- term illness such as hypertension, diabetes and atrial fibrillation (AF), are a tinderbox for attacks and the stroke burden, from illness to premature death, is predicted to double by 2030. “It is very frustrating because stroke is going under the radar and, although it can be devastat- ing, people are nowhere near as afraid of it as they are of cancer, heart disease and dementia,” says Mr Swindells. “Weareconvinced wecanmakesweep- ing advances if we get more funding. There are exciting areas of research into preventing and helping people re- cover from stroke, along with great progress in the UK on robot-assisted rehabilitation and theuseofstemcells. “The cost of dealing with stroke is enormous, so if we can prevent it and help people recover quickly, there will be a real economic bonus for the country as well as the bene- fit for patients. “Until comparatively recently it was thought that recovery from stroke would be luck of the draw, but we know the brain has plasticity and can recover. Size matters with research – and we need more funds.” The Stroke Association has been championing research for 25 years as well as providing services for survivors, while the British Heart Foundation currently supports 29 research projects, with £13.9 mil- lion invested directly into stroke, and further funds a wide variety of studies into atherosclerosis, a ma- jor cause of stroke. British universities and compa- nies are also pushing the bound- aries of innovation, and the Bridgend-based firm ReNeuron is showcasing promise with its novel CTX stem cell therapy to regener- ate motor function in stroke vic- tims which is now in phase II clini- cal trials. But there is still concern about the UK uptake of NOACs, a class of drugs also referred to as novel antico- agulants, which are prescribed to reduce the risk of stroke. Despite the National Institute for Health and Care Excellence (NICE) approving their use as part of a cardiovascular strategy in 2014, figures showed that less than 50 per cent of pa- tients admitted to hospital with stroke caused by AF had been tak- ing medication. The Association of the British Phar- maceutical Industry’s Stroke Preven- tion in Atrial Fibrillation Initiative (SAFI) is concerned about the alarm- ing range of NOAC prescription – from 4 to 70 per cent – across clinical commissioning groups (CCGs). “This means patients are sub- ject to a postcode lottery,” says Jo Taylor, vice chairwoman of SAFI. “Some 7,000 strokes and 2,000 premature deaths could be avoided each year with effective manage- ment of AF. “Consistent adoption of NICE guidance and widespread dissem- ination of best practice in service redesign in all CCGs is essential to save lives and prevent what are potentially avoidable AF-related strokes, benefitting patients, the NHS and the economy.” Treatment of strokes falls into two broad categories: acute care where early treatment is vital; and rehabilitation which can take months or years. The nation’s stroke services have been revitalised over the last decade, but rehabilitation is still the subject of much concern with variable levels of services and potential for dislo- cation between the authorities that share responsibility for post-hospi- tal care in the community. Patients are entitled to 45 min- utes’ daily rehabilitation in hospi- tal, be that occupational, speech or physiotherapy, but experts fear the gains are not always maximised when the patient returns home. In addition, the British Associa- tion of Stroke Physicians warns of gaps in the healthcare workforce with 25 per cent of stroke plac- es unfilled at training and con- sultant level, along with nursing shortages in some hyper-acute stroke units. Stroke services and public aware- ness have improved significantly, but the challenge to secure effec- tive and accessible treatment for all patients remains. DISTRIBUTED IN DANNY BUCKLAND Award-winning health journalist, he writes for national newspapers and magazines, and blogs on health innovation and technology. KEVIN GROGAN Specialist journalist coveringthepharmaceutical and healthcare sectors, he writes for a wide variety of publications on both sides of the Atlantic. JUDY HOBSON Renowned health writer, she has received awards from the Medical Journalists’ Association, Research into Ageing, and Excellence in Cancer Reporting. LORENA TONARELLI Healthcare journalist, she writes for The Independent, The Guardian and The Economist, as well as magazines and websites. RACONTEUR PUBLISHING MANAGER Senem Boyaci DIGITAL CONTENT MANAGER Sarah Allidina HEAD OF PRODUCTION Natalia Rosek DESIGN Samuele Motta Grant Chapman Kellie Jerrard PRODUCTION EDITOR Benjamin Chiou MANAGING EDITOR Peter Archer BUSINESS CULTURE FINANCE HEALTHCARE LIFESTYLE SUSTAINABILITY TECHNOLOGY INFOGRAPHICS http://raconteur.net/understanding-stroke-2016 CONTRIBUTORS Although this publication is funded through advertising and sponsorship,alleditorialiswithoutbiasandsponsoredfeatures are clearly labelled. For an upcoming schedule, partnership in- quiries orfeedback, please call +44 (0)20 8616 7400 ore-mail info@raconteur.net Raconteur is a leading publisher of special-interest content and research. Its publications and articles cover a wide range of topics, including business, finance, sustainability, health- care, lifestyle and technology. Raconteur special reports are published exclusively in The Times and The Sunday Times as well as online at raconteur.net The information contained in this publication has been ob- tained from sources the Proprietors believe to be correct. However, no legal liability can be accepted for any errors. No part of this publication may be reproduced without the prior consent of the Publisher. © Raconteur Media Funding for research could save many lives Stroke cuts lives short and has devastating effects on survivors, yet there is a desperate shortage of funding for research into its prevention and rehabilitation of patients OVERVIEW DANNY BUCKLAND Share this article online via Raconteur.net StrokeAssociation Source: Stroke Association, State of the Nation 80%of strokes could be prevented PUBLISHED IN ASSOCIATION WITH RACONTEUR raconteur.net 03UNDERSTANDING STROKE06 / 04 / 2016 UNDERSTANDING STROKE Stroke Association volunteers supporting a stroke survivor
  • 3. 334 x 96mm RACONTEUR raconteur.net 05UNDERSTANDING STROKE06 / 04 / 2016 Gareth Beevers, professor of medi- cine at the University of Birmingham and a trustee of Blood Pressure UK, says: “High blood pressure is by far the most important risk factor for stroke. In fact, when antihypertensive drugs became widely available in the 1960s, strokes were substantially reduced.” In a review of 14 clinical trials in- volving a total of 370,000 people with high blood pressure, antihypertensive drugs such as beta-blockers (heart rate lowering medications) and diu- retics (water pills) reduced strokes by 35 to 40 per cent. However, other factors are at play. Obesity, diabetes, high blood choles- terol, lack of exercise, smoking and excessive alcohol consumption all in- crease the chances of having a stroke. And these are greater for individuals with atrial fibrillation (irregular heart- beat) and people who have a family history of stroke, or are of south-Asian or African-Caribbean background. As for increasing age, it’s worth noting that, while strokes are more likely among the elderly, one in four affect people younger than 65, accord- ing to the Stroke Association. This plethora of risk factors means blood pressure shouldn’t be consid- ered in isolation, but in the context of other patient characteristics, explains Dr Nicholas Summerton, a GP in East Yorkshire and former clinical adviser in primary care diagnostics to the De- partment of Health. “A high reading matters more if, for example, you have diabetes or are a smoker. And a normal reading doesn’t necessarily mean you are problem free. It depends on your overall stroke risk,” he says. twelve months if their blood pressure is borderline. The current recommen- dation is that higher-than-normal blood pressure should be brought below 140 over 90. But the general con- sensus is that interventions should be more aggressive and aim for readings below 120 over 80.” Pippa Tyrrell, professor of stroke medicine at the University of Manches- ter, agrees and highlights the impor- tance of monitoring approaches that can help with this, such as ambulatory blood pressure monitoring, whereby patients are fitted with an electronic device that measures their blood pressure throughout the day astheymovearound, and self-monitoring at home. “They provide a largeamountofdata from readings taken in the patient’s own environment, helping with diagnosis and treatment decisions,” says Pro- fessor Tyrrell. Plus, evidence suggests that home self-monitoring, which a survey by the University of Birming- ham estimates is already used by about 30 per cent of UK hypertensive patients, may improve health out- comes. In a study published in The Journal of the American Medical Association, by an Oxford University team headed by Professor Richard McManus, self-monitoring led to greater blood pressure reductions than readings reg- ularly taken by a doctor. “Wearable technology can also help with certain risk factors,” says Dr Summerton. “For example, pulse monitors can detect heart- beat irregularities due to atrial fi- brillation, which is associated with a five-fold increased risk of stroke. And fitness bands seem to encour- age people to exercise more. But the evidence supporting wearables’ ef- ficacy is limited.” So there really are effective ways to control high blood pressure, address other risk factors and, ultimately, reduce the likelihood of a stroke. And these same measures can help those who have already had one. Therefore, the majority of strokes shouldn’t occur. As Professor Beevers concludes: “They should be almost a thing of the past.” High blood pressure is by far the most important risk factor for stroke Share this article online via raconteur.net Doctors can calculate a person’s stroke risk using a computerised tool (QRISK2) recommended by the National Institute for Health and Care Excellence, which provides na- tional guidance on disease preven- tion and treatment. Thisenablestimely,personalisedpre- vention. And prevention can save lives. In a report on hypertension, Public Health England says: “In ten years, 45,000 years of life could be saved, and £850 million not spent on related health and social care, if we achieved a reduction in the average population blood pressure.” But, achieving this goal requires a col- laborative effort. On one hand, govern- ment and health- care commission- ers and providers must promote and support preven- tion. There are examples, such as the Department of Health’s Change4Life campaign, which encourages people to eat healthy and exercise more, and the NHS Health Check, a mid-life MOT offered to everyone aged 40 to 74. On the other hand, individuals must be willing to embrace prevention. The good news is there are effec- tive ways of integrating prevention in everyday life. Lucy Wilkinson, senior cardiac nurse at the British Heart Foundation, recommends “reducing salt intake to less than six grams per day, as this is directly linked to hypertension; aiming for at least 150 minutes of moderate-in- tensity physical activity a week; and losing excessive weight”. She says: “Avoiding smoking and excessive alcohol consumption is also important. New guidance advises men and women to drink no more than 14 units of alcohol a week, and to have at least two or three alcohol-free days.” People should also have regular blood pressure checks. This is key to the early detection and treatment of hypertension, for the condition devel- ops silently over many years, before the first symptoms become obvious. Ms Wilkinson points out: “Nearly 30 per cent of adults in the UK have high blood pressure, but about half – around seven million people – are not receiving treatment be- cause they don’t know they have the condition.” Professor Beevers adds: “Every adult should have their blood pressure checked every five years or every six to It’s possible to make strokes a thing of the past Being aware of the risk factors and taking preventative measures can greatly reduce the chances of becoming a victim of stroke T he key to reducing the frighteningly high inci- dence of stroke is taking control of the modifiable risk factors for the condition. And number one of these factors is high blood pressure or hypertension, which is a contributing cause in more than 50 per cent of strokes, according to the Stroke Associa- tion’s State of the Nation: stroke sta- tistics report. The NHS says that ideally blood pressure should be below 120 over 80. . Readings above 140 over 90 are considered hypertension. This puts strain on blood vessels, increasing the likelihood of strokes. PREVENTION LORENA TONARELLI A stroke is when the blood flow to part of the brain is cut off or reduced. It is also known as a “brain attack”. When it happens, brain cells no longer get the nutrients and oxygen they need to function and begin to die. This can cause lasting damage to the functions or parts of the body the cells control. For example, a stroke may result in difficulties talking, swallowing, moving one arm or walking. There are two main types of stroke: ischaemic stroke; and haemorrhagic stroke. Ischaemic strokes are the most common, accounting for about 85 per cent of cases, according to the Stroke Association’s State of the Nation report. They occur when a blood vessel that supplies the brain becomes blocked. This can happen because of a blood clot that forms in the brain (thrombotic stroke), or because of a blood clot or air bubble that forms around the body and travels up to the brain (embolic stroke). Ischaemic strokes can also be caused by a fatty material, called plaque, which builds up inside blood vessels reducing blood flow. This is known as atherosclerosis. Haemorrhagic strokes occur when blood vessels in the brain leak or burst causing bleeding. In this case, brain cells die because of the build-up of pressure from the bleeding. Haemorrhagic strokes can happen inside the brain (intracerebral haemorrhage) or in the space between the brain and the tissue that protects it (subarachnoid haemorrhage). They are rarer, but generally more serious, than ischaemic strokes. WHAT IS STROKE? Source: Stroke Association, State of the Nation PREVALENCE OF HIGH BLOOD PRESSURE IN THE UK PEOPLE REGISTERED AS HYPERTENSIVE 2005 11.4% 13.8% 13.9% 12% 12.6% 12.9% 13.2% 13.4% 13.6% 13.7% 2006 2007 2008 2009 2010 2011 2012 2013 2014 people in the UK are registered as hypertensive; an additional 6.8 million are thought to be undiagnosed 9.2m+ Medfield Diagnostics is developing a unique method to diagnose stroke using microwave technology, which is portable, safe and fast. The device weighs 6 kg, uses less than 1% of the power emitted by a mobile phone And gives a diagnostic answer in less than a minute. It is battery operated and well suited to be used pre- hospitally, at the scene of the incidence. During an acute stroke,brain cells, deprived of oxygen, die at a rate of two million cells per minute. The sooner treatment to restore oxygen supply is applied the less brain damage and a faster recovery for the patient. Fast ambulance based diagnostics leads to more options. During a stroke, brain tissue dies due to lack of oxygen The cause of a stroke was known in the ambulance - The time to treatment could be shortened - Patient suffering could be reduced - More patients could be optimally treated - Savings could be made in care and rehab costs Info@medfielddiagnostics.com | medfielddiagnostics.com | +46 31 160 668 What If? Early Diagnosis Opens up for more possibilities   WHAT  IF?   Stroke  origin  was  known  in  the  ambulance   Time  to  treatment  could  be  shortened   Patient  suffering  could  be  reduced   More  patients  could  be  treated  optimally   Savings  could  be  made  in  care  and  rehab  costs   Medfield   Diagnostics   is   developing   a   unique   method   to   diagnose   stroke  using  microwave  technology,  which  is  portable,  safe  and  fast.   The  device  weighing  <  6  kg,  using  <  1%  of  the  emission  from  a  mobile   phone  and  giving  a  diagnostic  answer  in  less  than  a  minute.  It  is  battery   operated  and  well  suited  to  be  used  pre-­‐hospital,  at  the  scene  of  the   incidence.           During a stroke, brain tissue dies due to lack of oxygen During an acute stroke, ca. 2 million brain cells die per minute. Faster treatment to restore oxygen supply leads to less brain damage and a faster recovery for the patient. 85% of the stroke cases are due to a clot and 15% are due to bleeding. Thrombolytic treatment is a proven efficient clot buster but must be administered within 4.5 hours of the onset of the stroke to be effective and is detrimental if administered to a patient suffering from a bleeding stroke. Due to this, the cause of the stroke has to be determined before thrombolytic treatment can be administered. Today, the differentiation is made using a CT or MR scan at the hospital, which means that the lead time from onset of stroke to diagnosis often exceeds 4.5 hours. As a result, only 1-8% of stroke patients receive this highly effective treatment Early  Diagnosis   Opens  up  for  more  possibilities   Therapy  options   Hospital  options   Transport  options   Therapy options Hospital options Transport options The dedication to drive patient care forward? Do You Have We are currently collaborating with research oriented organisations who are interested in the development of stroke and trauma care. Do you want to join us?
  • 4. UNDERSTANDING STROKE raconteur.net06 RACONTEUR RACONTEUR raconteur.net 07UNDERSTANDING STROKE06 / 04 / 2016 06 / 04 / 2016 Source: World Stroke Organization 11.9%of all deaths worldwide are caused by stroke 1in6people in the world will suffer a stroke in their lifetime TREATMENT RECORD DANNY BUCKLAND UK is playing catch-up to improve stroke outcomes The UK lags behind other developed nations in the league table of stroke treatment and, despite some notable achievements, there remains much to do L ess than a decade ago, a dis- turbing public health report discovered that scanners needed to diagnose stroke vic- tims were kept under lock and key after office hours. An antiquated service also saw the technology positioned away from Accident and Emergency depart- ments making it difficult for doctors to confirm their diagnosis. Only 58 per cent of patients were given a scan within 24 hours, while at the Princess of Wales Hospital in Grimsby, the report noted, the aver- age weekday waiting time for scan- ning results stretched to 48 hours – and stroke is a condition that waits for no man or woman. The historical landscape of stroke goes some way to explain the lethal deficiencies in the service. The word stroke only came into common med- ical use in the 1960s, replacing the term apoplexy – from a Greek deri- vation meaning thunder struck – to describe what seemed to be a sudden and random affliction. Rehabilitation from stroke was not regularly featured in medical text- books until the late-1950s, according to the 1997 Age and Ageing report, as understanding of what was then iden- tified as a problem of internal bleed- ing was still playing catch-up. Stroke services in England were officially graded as “poor” by the National Audit Office (NAO) in 2005, and a mammoth task of recalibrating public awareness, facilities, staff and delivery was instigated. The campaign’s success is one of the NHS’s towering achievements – death rates have been almost halved in a decade – but clinicians are still fearful that life-saving and affirming treat- ments are not getting to patients. Also fresh government strategies could unpick the hard-earned progress. At the same time, figures from the World Health Organization show the UK still lags behind other, poorer na- tions in crucial aspects of morbidity and mortality. Its Atlas of Heart Disease and Stroke records 15 million strokes globally every year, which leave five million dead and five million with permanent disability. The UK is positioned in the 10,000 to 99,999 bracket, denoting a death rate higher than Scandinavia, Belgium, Switzerland, Slovenia, Croatia, and some Arab and African nations. Some of the disparity can be ex- plained by different national re- porting methods, but the emerging consensus is that the UK’s stroke services still need to improve before it can attain world-class status across the treatment disciplines. The government’s response to the NAO 2005 shock was to give stroke tier-1 importance and load it with financial incentives, while the Royal College of Physicians launched the Sentinel Stroke National Audit Programme to provide important annual route markers of services. “Both were important because, if you don’t know where you are, it is very difficult to tell when you will reach your destination,” says senior stroke consultant Damian Jenkinson, whose unit at the Royal Bournemouth Hospital was one of the first in the country to offer clot-busting thrombolysis treat- ment around the clock, as well as pioneering telemedicine to make rapid treatment decisions. “Major improvements have oc- curred since the National Audit Office declared that services were poor quality and poor value for money. They could see by looking at care elsewhere on the planet that invest- ing in certain parts of the pathway, and getting people with acute stroke into each stroke unit really quickly was going to improve the care and be efficient, effective and cheaper.” Services and performance were re- vitalised by setting up 28 stroke-spe- cific networks, and the FAST – face, arms, speech, time – acronym pub- lic-awareness campaign to enable swift recognition of the early symp- toms of stroke gained traction. But many experts feel the impetus has stalled. “It has sort of gone off the boil politically,” says Dr Jenkinson, a former national clinical director for stroke, who now works at Dorset County Hospital. “We are getting to- wards the end of the ten-year stroke strategy and lots of other strategies have landed on commissioners’ desks in the meantime. There is a feeling in the stroke community that the emphasis has waned. “The Stroke Association is challeng- ing the government to give the strat- egy a refresh and have a new era in stroke. It is a major challenge to finish off this work, but it feels, at shop-floor level, like there is a move to create more generic units where stroke vic- tims will be treated alongside hip frac- tures and pneumonia patients.” The contributory factors for stroke are similar to heart attacks, namely smoking, hypertension, atrial fibril- lation and lifestyle-induced condi- tions such as obesity and diabetes. Drug therapies play a huge part in treatment with new ranges of an- ti-coagulants controlling blood flow and minimising the risk of a block- age to a cerebral artery. But a significant blot on the na- tion’s stroke service copybook is in the patchy use of recent devel- opments in mechanical thrombec- tomy where a catheter is inserted, normally via the groin, to guide a stent to the site of a clot where it can be grabbed and removed quickly to restore blood flow to the brain. Sanjeev Nayak, a consultant neuro- radiologist at Uni- versity Hospitals of North Midlands NHS Trust, in Stoke, who has pioneered the technique since 2009, believes thrombectomy can be performed on up to 15,000 patients with acute ischae- mic stroke a year, saving lives and reducing the level of disability for stroke survivors. “The main concern is about the infrastructure – and the UK is way behind Europe and the United States when it comes to mechanical thrombectomy,” he says. “Despite the clinical evidence, less than 500 patients are treated annually within the UK with mechanical thrombec- tomy, when there are at least 8,000 to 15,000 eligible patients per year, which in my opinion is scandalous. This is due to lack of infrastructure and funding issues. “In contrast, some 9,000 patients are treated in Germany. Developing the infrastructure with appropriate funding to deliver such a service in the UK should be a priority.” His case list includes some star- tling results including a pregnant It is almost as if stroke has had its day and the spotlight has switched to other areas such as cancer or dementia 27-year-old who was admitted in March with paralysis down the right side, and both her and the baby’s future in the balance. Dr Nayak was able to remove the clot in a 15-minute procedure and the woman walked from the hospital with no ill-effects and the pregnan- cy still viable. Post-acute care is a key area where services need to improve through the early supported dis- charge scheme that provides re- habilitation at home for up to six weeks. Government figures show 25 per cent of clinical commissioning groups do not provide this. “There is still a feeling that people get abandoned and there aren’t enough community support teams,” adds Dr Jen- kinson. “We man- aged to reorganise care delivery in 170 hospitals, but it is proving harder to deal with the 90,000 patients discharged after stroke every year. Follow-up is a challenge and only a third of them go for their six-month check-up.” Marion Walker, professor in stroke rehabilitation at the Uni- versity of Nottingham, concludes: “It is almost as if stroke has had its day and the spotlight has switched to other areas such as cancer or de- mentia. However, the stark figures tell the story: this is a condition with high morbidity and mortality. We still haven’t cracked it and there is a gathering realisation of this and the need to bring the spotlight back on to stroke. “There is life after stroke. It may be different, but it can be a very good life. People can still enjoy their family, friends, hobbies and get back to work. We have made huge strides in the last couple of decades and it has been a privilege to be a part of that, but there is still much to do.” RUSSIA MACEDONIA GUYANA BULGARIA TURKMENISTAN ROMANIA PHILIPPINES UKRAINE LATVIA KAZAKHSTAN MONGOLIA LITHUANIA CROATIA JAMAICA SOUTHAFRICA HUNGARY SLOVAKIA BRAZIL TURKEY GREECE CUBA POLAND PORTUGAL CHILE KUWAIT KOREA ARGENTINA UAE NEWZEALAND MEXICO ITALY SINGAPORE JAPAN EGYPT IRELAND UK SWEDEN GERMANY BELGIUM AUSTRALIA NORWAY BAHRAIN HONGKONG SPAIN US THAILAND QATAR CANADA FRANCE 139.9 138.1 133.9 126.3 118.3 114.8 112.7 106.9 97.7 90.3 83 80.2 70.1 65.4 61.9 58.2 55.1 52.8 49.1 47.9 44.8 43.6 40.5 36.6 35.3 34.6 32 31.6 30.1 29.9 29.5 27.8 26.5 25.7 24.9 24.5 24.4 23.9 23.6 22.7 22.3 22 21.4 20.6 20.5 19.3 7.9 17.4 17.9 AUSTRIA20.8 GLOBAL MORTALITY RATES FROM CEREBROVASCULAR DISEASE* AGE-STANDARDISED DEATH RATES PER 100,000, FOR SELECTED COUNTRIES WITH LATEST AVAILABLE DATA 48-67 68-85 86-104 105-122 123-143 UK STROKE MORTALITY RATES AGE-STANDARDISED DEATH RATES FROM STROKE PER 100,000 AVERAGE MORTALITY RATES FROM CEREBROVASCULAR DISEASE, BY REGION* AGE-STANDARDISED DEATH RATES PER 100,000; AVERAGES BASED ON SELECTED COUNTRIES WITH LATEST AVAILABLE DATA TOP 10 LEADING CAUSES OF DEATH WORLDWIDE BY NUMBER OF DEATHS IN MILLIONS 58.58 Africa 42.88 Europe 23.24 Middle East 18.95 North America Source: British Heart Foundation 2015 Source: WHO Source: WHO 2014 Source: WHO/Raconteur analysis TOP 5HIGHEST AND LOWEST STROKE MORTALITY RATES IN THE UK AGE-STANDARDISED DEATH RATES FROM STROKE DISEASE PER 100,000 Region Northern Ireland Northern Ireland Scotland Scotland Yorkshire and The Humber Region East Midlands East Anglia London South East London ASDR per 100,000 140.4 135.8 121.7 120.6 111.9 ASDR per 100,000 48.3 49 49.5 49.7 50.4 HIGHEST Local authority Ballymena Cookstown Renfrewshire West Dunbartonshire Scarborough LOWEST Local authority South Northamptonshire Babergh Richmond upon Thames Swale Westminster Source: Stroke Association, State of the Nation 13Every 13 minutes stroke will take someone’s life in the UK 7%of all deaths in the UK are caused by stroke 1.1 Hypertensive heart disease 1.3 Road injury 1.5 Diabetes 1.5 Diarrhoeal diseases 1.5 HIV/Aids 1.6 Lung cancer 3.1 Lower respiratory infections 3.1 Chronic obstructive pulmonary disease 7.4 Ischaemic heart disease 6.7 Stroke 36.54 Latin America 38.19 Asia-Pacific 102.91 Former Soviet Union *Global statistics are for cerebrovascular disease, a common cause of stroke
  • 5. RACONTEUR raconteur.net 09UNDERSTANDING STROKE06 / 04 / 2016 floors of medical conferences” as thrombectomy data is presented. In a Canadian meta-analysis of eight trials involving more than 2,400 patients presented in April last year, for example, thrombec- tomy was associated with much improved functional outcomes at 90 days compared with standard medical care using thrombolyt- ics (44.6 per cent against 31.8 per cent respectively). How many patients will benefit from thrombectomy in the UK is still unclear, but Dr Webb says: “If you are one of these patients, this is absolutely life-transforming.” In February, NICE updated guid- ance backing thrombectomy, but a full technology appraisal is needed to get the mandate that would help M ajor strides have been made in the understand- ing of stroke in the last fewyearswithsignificant advances in imaging and medicines. In particular, there are now four oral an- ti-coagulants to prevent stroke in atri- al fibrillation patients on the market. However, the innovation causing the biggest stir among stroke clini- cians is thrombectomy, also known as mechanical clot retrieval. The technique involves inserting a cath- eter into a large blood vessel, usual- ly in the groin, and locating the clot through a cerebral angiography; a device is then inserted through the catheter to pull the clot out. At present, thrombolytics are used to dissolve blood clots, but these must be given within four- and-a-half hours of the start of the stroke and only benefit around one in seven people treated, according to the National Institute for Health and Care Excellence (NICE). Thrombectomy has impressed cli- nicians treating patients with larger clots, which are likely to lead to greater disability due to blood flow being interrupted for longer. Pro- fessor Tony Rudd, national clinical director for stroke with NHS Eng- land, says the technique is “top of the list” of recent innovations. “In the last 15 months, we have had five trials which have shown it is highly effective,” he says. His enthusiasm is shared by Dale Webb, director of research and in- formation at the Stroke Associa- tion, who says that “over the last year and a half, people have been whooping and cheering on the get the procedure routinely com- missioned across the NHS. Professor Rudd also notes that the challenge is to get enough trained interventional neuro-radiologists to perform such highly skilled pro- cedures. However, the cost of train- ing staff and setting up dedicated thrombectomy units is less than the financial burden of having to treat people with long-term disability caused by stroke. Another area causing excitement is the use of stem cells to reverse some of the disabling effects of stroke. One of the leading lights in this field is Professor Keith Muir of the University of Glasgow’s Institute of Neuroscience and Psychology, who has been involved in a phase I trial undertaken from 2009 to 2015 involving 11 people with disabling long-term effects of stroke. Different doses of cells were inject- ed deep into the brain, close to the location of the stroke damage. He says: “We observed improvements in various abilities in several patients, which was interesting given how late after the stroke we included people.” Professor Muir stresses that the study was not designed to demon- strate efficacy, “so these intriguing observations need to be further in- vestigated”, he says. To this end, a phase II study has been running at a number of UK hospitals since mid- 2014, which aims to investigate the recovery of arm function, and initial data is expected to be reported in around 20 patients this summer. It is clearly early days, but Professor Muir says: “In general, it is now be- lieved that cell-therapy approaches are probably acting by modifying the body’s response to injury, stimulat- ing recovery and reducing harmful effects of inflammation.” The stud- ies will give detailed information on the safety and feasibility of deliver- ing cells by injection into the brain within a few months of a stroke. A small study from Oxford’s Nuff- ield Department of Clinical Neuro- sciences found that patients who were given electrical brain stimula- tion alongside rehabilitation fared better than those on rehab alone. The trial, published in the Journal of Science Translational Medicine, in- volved 24 people who had strokes at least six months previously and still experienced difficulties moving their hands and arms. The recovery of function in long- term patients is an important area, but INNOVATIONS KEVIN GROGAN with stroke, time is very much of the essence in limiting brain damage. Dr Webb at the Stroke Association points to a microwave helmet, developed in Sweden by Medfield Diagnostics, which is being trialled in ambulances and could slash diagnosis times. Professor Joanna Wardlaw, chair of appliedneuroimagingandheadofneu- roimaging sciences at Edinburgh Uni- versity, believes the next big innovation will be treatments for small-vessel or lacunar stroke, which she says could also have a big impact on dementia. A lacunar stroke is caused by damage to one of the small vessels deep within the brain and accounts for around one in four strokes. The British Heart Foundation, which is helping to fund a three-year trial led by Professor Wardlaw, cites research- ers who believe it could be an under- lying cause of at least 40 per cent of all dementias. There is currently no approved treatment for a lacunar stroke and in the trial around 200 patients will be treated with either cilostazol, isosorbide mononitrate or both, two drugs currently used to treat angina and peripheral vascular disease. By performing MRI scans on people taking part in the trial, Professor Wardlaw and colleagues will monitor whether the drugs have an effect on the small vessels of the brain. Thrombectomy, stem cell ther- apy and testing two old, and very cheap, drugs that could help pre- vent dementia following stroke are promising developments with the potential of saving lives and trans- forming outcomes. Breakthroughs in the battle to beat stroke Innovative new procedures and drugs are giving fresh hope for stroke patients as clinical trials show encouraging results Share this article online via raconteur.net Cell-therapy approaches are probably acting by modifying the body’s response to injury, stimulating recovery and reducing harmful effects of inflammation The innovation causing the biggest stir among stroke clinicians is thrombectomy, also known as mechanical clot retrieval Corbis 01 Thrombectomy performed under cerebral angiography on a patient with stroke symptoms at CHU Bordeaux 02 Strokefinder microwave helmet prototype, devel- oped by Medfield Diagnostics and Chalmers Univer- sity of Technology, has the potential to cut diagnosis times dramatically 02 01 RESEARCH SPENDING ON DIFFERENT DISEASES IN THE UK Source: Stroke Association 2012 Cancer Spending on research by charities and governmental organisations left axis Spending on research per person with the disease right axis Coronary heart disease Dementia Stroke £600m £500m £400m £300m £200m £100m £0 £300 £250 £200 £150 £100 £50 £0 GunillaBrocker 1. Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N. Engl. J. Med. Jun 11 2015;372(24):2285-2295. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device. CAUTION: Federal (U.S.A.) law restricts this device to sale by or on the order of a physician. © 2016 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. 16-eu-solitaire-advert-en-306893 Positive Clinical Outcomes (mRS 0-2)1 60% SolitaireTM Device Utilization in SWIFT PRIME1 100%BETTER BY DESIGN. BACKED BY DATA. SolitaireTM Revascularization Device 0% Symptomatic Intracerebral Haemorrhage sICH1
  • 6. UNDERSTANDING STROKE raconteur.net10 RACONTEUR06 / 04 / 2016 RACONTEUR raconteur.net 11UNDERSTANDING STROKE06 / 04 / 2016 COMMERCIAL FEATURE RACONTEUR raconteur.net 2XXXXxx xx xxxx COMMERCIAL FEATURE CLINICAL RESULTS INCREASE CALLS FOR NEW NHS STROKE TREATMENT A procedure that mechanically removes a blood clot in stroke patients is achieving notable results and cutting care costs T he results of important clinical trials, published in the last 15 months, have shown mechanical thrombectomy can improve recovery from stroke and have led to increased demands to make it available on the NHS. Using thrombectomy to remove a blood clot causing an acute ischaemic stroke was found to be safe and effective by the recent PISTE trial at 11 UK hospitals and other studies in the United States and Canada. The PISTE findings, presented at the International Stroke Conference in Los Angeles last month, showed that at three months after the stroke, 20 per cent more patients in the group who had received thrombectomy made a full neurological recovery compared to the group getting standard treatment alone. The study, funded by the Stroke Association and the National Institute for Health Research, adds to a growing body of clinical research that the procedure is safe and effective within the NHS. Physicians can treat smaller blockages causing strokes with thrombolysis, but larger clots, identified byCT scan and angiogram, can benefit more from direct intervention by a thrombectomy which uses a stent procedure to remove the clot from harm’s way. Time is a crucial factor with a target to start operating of four-and-a- half hours or less from onset. Pioneering consultant neuroradiologist Dr Sanjeev Nayak believes more widespread use of thrombectomy is imperative to save lives and realise substantial savings to the NHS and social care budgets. His unit at the University Hospitals of North Midlands NHS Trust (UHNM), in Stoke-on-Trent, Staffordshire, was the first to introduce the procedure routinely in 2009 and has performed more thrombectomies than any other hospital in the UK. “Prior to using mechanical thrombectomy, it was thrombolysis where you give a clot-busting drug,” he says. “But it worked in less than 10 per cent of patients whose main artery to the brain was occluded by a large clot. These patients with large strokes would either die or survive with a severe disability often requiring 24/7 care throughout their lives. “With these advances we can pull out the clot and immediately open the vessel, and not have to wait for a drug to dissolve it. “We have had patients who have come in with no movement at all being able to walk out of the hospital two days later. The benefits clinically and financially are notable.” A cost analysis based on 200 patients treated between 2010 and 2014 at UHNM demonstrated that the hospital had saved £3.2 million by freeing up bed space and a further £16 million from social care budgets. “The big problem is that patients are not aware of this service and the time limits,” says Dr Nayak, who has contributed data to the National Institute for Health and Care Excellence (NICE), which is currently conducting a health economic review of thrombectomy procedures. “We are saving lives immediately, but there is no infrastructure to support it. We need a rapid-response ambulance service and 24-hour cover. This needs to be a round-the-clock service. “The NHS spends £8.9 billion a year treating strokes and we have the potential to save billions from that cost if this service is done properly. It can make a big difference to people’s lives but it needs investment. “We have calculated that around 8,000 to 30,000 patients a year could benefit from this and, even if you reach less than 50 per cent of them, you are still saving 10,000 lives a year which is incredible.” Christine Roffe, a stroke physician at the Royal Stoke University Hospital and professor of stroke medicine at Keele University, believes the trials’ evidence points clearly towards thrombectomy becoming a standard feature of future NHS treatment. “The evidence is now uncontroversial that thrombectomy is more effective than thrombolysis when it can be given,” she says. “It is a better treatment and allows the patients to recover. The ‘number needed to treat’ (NNT) to save one patient from a long-term dependence life is three to seven, which is very low. The NHS normally pays for anything with a NNT of 40 or below.” Thrombectomies are more expensive than thrombolysis as they require a full neurointerventional team, but at around £10,000 they still offer cost benefits because patients can return to full lives without social care, says Professor Roffe. “We are still waiting for the formal health-cost analysis and NICE commissioning guidelines, and we will have to look at the infrastructure so we can implement it, but I believe it could be established quickly once we have the political determination,” she adds. Clinicians want to see a series of ten to fifteen regional centres of excellence where interventionists can stay in practice to maintain high levels of success. www.stryker.com With these advances we can pull out the clot and immediately open the vessel, and not have to wait for a drug to dissolve it At Stryker Neurovascular, our approach to Complete Stroke Care centres on a culture of innovation and partnerships, from introducing breakthrough technologies and investigating leading- edge therapies, to providing ongoing training and improving reimbursement. A recognised leader in ongoing innovation for the treatment of ischemic and hemorrhagic stroke, Stryker Neurovascular is committed to delivering a full spectrum of advanced products for Complete Stroke Care. Through research and development of game- changing technologies, we are dedicated to real innovation with a purpose. COMPLETE STROKE CARE® Gaming tech can beat patchy provision Stroke survivors face a postcode lottery when it comes to rehabilitation services, but a version of gaming technology may provide the answer to improving at-home therapy W hile acute care of stroke patients in many parts of England and Wales is now world class, the long-term support and rehabilitation of stroke survivors is lagging behind. Inaclinicalauditofpost-strokeservice providers, published in December, it is described as “very patchy”. The audit, by the Royal College of Physicians on behalf of the Intercol- legiate Stroke Working Party, points out that psychological support for those who suffer what is often a life-changing event is as important as physical support. But it found the median waiting time for patients needing such support was ten weeks, with around 25 per cent having to wait five months or longer. Alexis Wieroniey, the Stroke Associ- ation’s deputy director for policy and influencing, says: “The improvements we’ve seen in emergency care are not being matched in rehabilitation. Even in hospital, stroke survivors don’t always get the amount of rehab thera- py they should.” According to the Stroke Association’s State of the Nation: stroke statistics report, around 45 per cent of stroke survivors are left with swallowing diffi- culties, putting them at risk of choking on small pieces of food. Speech and language therapists are trained to help them, and under National Institute for Health and Clinical Excellence (NICE) guidelines they should have 45 min- utes of this therapy every day. On average, according to a stroke clinical audit published in Janu- ary, they only get 41.9 per cent of the speech and language therapy recom- mended. Access to physiotherapy and occupational therapy (OT) while they are in hospital is better, with stroke survivors getting 74.5 per cent of the physiotherapy they should and around 80 per cent of OT. The principal reason stroke survi- vors do not always get the amount of rehab therapy they need is staff shortages. One way to address shortfall in physiotherapy provision would be the introduction of online thera- py, enabling patients with moder- ate-to-mild disability to play inter- active computer games to help them regain movement. A company called EMVIGR has set up a cloud-based platform that would enable recovering stroke patients, in hospital,athomeoronholidayabroad, to access interactive online games that involve them carrying out a range of upper-limb movements. The company, established by New- castle University academics Janet Eyre, professor of paediatric neurosci- ence, and Dr Graham Morgan, a com- puting scientist, with funding from the Health Innovation Challenge Fund, is awaiting final approval for its system from the Medicines and Healthcare products Regulatory Agency, and is in talks with the NHS. Professor Eyre says: “We’re keen to get this out to patients and are talk- ing to the distributors who market products to NHS hospitals. We’ve also had approaches from India, China and Australia, and are opti- mistic that by the end of this year we’ll have signed contracts.” Six different games have been tested. Professor Eyre envisages that after playing the games in hospital, stroke survivors will continue playing at home on their PC or laptop for a small licence fee. She says: “We know that the bigger the dose of physiotherapy a stroke patient gets the better the outcome. While the patient may get one-to- one physiotherapy in hospital, at home they have to do exercises by themselves. They often find this boring, but when they play a com- puter game they get engaged and reward hormones kick in. “Progress is assessed remotely by a therapist, who can e-mail or phone the patient when it is time for them to move on to a more dif- ficult game.” Every year in the UK around 26,000 stroke survivors are left with some kind of long-term facial paralysis. Often they are simply given an A4 sheet of exercises to do in front of a mirror. Philip Breedon, professor of smart technology at Nottingham Trent Uni- versity,believesthisisabouttochange. In a project funded by the Nation- al Institute for Health Research in- vention for innovation programme, Professor Breedon and his team have used gesture recognition sensors from gaming technology to develop a “face-to-face” system for patients to use at home. “The beauty of this technology is that it allows the exercises to be tailored to the needs of the indi- vidual patient, and changed if and when necessary. Both patients and therapists like it, and our aim is for it to be used in clinical practice,” he says. REHABILITATION JUDY HOBSON “In July, a trial will follow the pro- gress of 80 stroke patients with facial paralysis for the next two years. Patients will get feedback on their screens to allow them to see how they’re doing, and a speech and lan- guage therapist will be able to com- municate remotely with them and check their progress. “We hope this will lead to it becom- ing commercially available and being taken up by the NHS.” Penny Standen, professor of health psychology and learning disabilities at Nottingham University, has been evaluating home-based gaming inter- ventions for stroke rehabilitation. She says: “I would say we’re three quarters of the way there. The big question is who will pay. NICE will want a high level of evidence to show they’re effective before recommend- ing use on the NHS. “Their big advantage is that they’re consistent, don’t get fed up with you making mistakes, don’t get distracted and don’t get bored, and allow people to do exercises whenever they want. I see them as complementary to tradi- tional therapy.” Share this article online via raconteur.net The principal reason stroke survivors do not always get the amount of rehab therapy they need is staff shortages NottinghamTrentUniversity Video gaming technology is used to help patients left with facial paralysis after a stroke EFFECTS OF STROKE PERCENTAGE OF STROKE PATIENTS AFFECTED Source: Stroke Association, State of the Nation 33% Bowel control 33% Depression 33% Aphasia 45% Swallowing 50% Bladder control 50% Slurred speech 54% Facial weakness 60% Visual problems 72% Lower limb/ leg weakness 77% Upper limb/ arm weakness